Wei Shen Tan, MD, PhD
Urology
Patient type treated
Adult
Accepting new patients
Yes
Referral required
Not Applicable
Board Certified in
Urology
Titles
- Assistant Professor
Education & Training
- Fellow, Urologic OncologyUniversity of Texas MD Anderson Cancer Center
- Fellow, Robotic UrologyUniversity College London Hospitals
- Resident, UrologyLondon School of Surgery
- Non Degree ProgramRoyal College of Surgeons of England
- PhDUniversity College London
- MDCardiff University
- BScUniversity College London
Additional Information
Board Certifications
- Royal College of Surgeons of England, Urology (2022)
Publications
- Taylor J, Kamat A, O'Donnell M, Annapureddy D, Howard J, Tan W, McElree I, Davaro F, Yim K, Harrington S, Dyer E, Black A, Kanabur P, Roumiguié M, Lerner S, Black P, Raman J, Preston M, Steinberg G, Huang W, Li R, Packiam V, Woldu S, Lotan Y. Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer. BJU International 2024 PMID: 39183466, DOI: 10.1111/bju.16509.
- Li R, Hensley P, Gupta S, Al-Ahmadie H, Babjuk M, Black P, Brausi M, Bree K, Fernández M, Guo C, Horowitz A, Lamm D, Lerner S, Lotan Y, Mariappan P, McConkey D, Mertens L, Mir C, Ross J, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess P, Svatek R, Tan W, Taoka R, Buckley R, Kamat A. Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. European Urology 2024 PMID: 39183090, DOI: 10.1016/j.eururo.2024.08.001.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect? European Urology 2024 PMID: 38879371, DOI: 10.1016/j.eururo.2024.05.027.
- Tan W, Ta A, Sridhar A, Kelly J. Male Robot-Assisted Radical Cystectomy with Nerve Sparing Technique. 2024, 291-302. DOI: 10.1007/978-3-031-49428-4_23.
- Tan W, Ahmad A, Zhou Y, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Smith R, Khalifeh M, Tan W, Cohen D, Volanis D, Walter F, Sasieni P, Kamat A, Kelly J. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria. European Urology Oncology 2024 PMID: 38811250, DOI: 10.1016/j.euo.2024.05.005.
- Grajales V, Contieri R, Tan W, Tuke D, Akhverdiyeva L, Hwang H, Myers A, Kamat A. MP35-06 PICTURE PERFECT DIAGNOSES: EVALUATING UROLOGISTS' TUMOR IDENTIFICATION SKILLS: THE PROSPECTIVE TUMOR GRADING VISUAL ACCURACY (TRIVIA) STUDY. Journal Of Urology 2024, 211: e582. DOI: 10.1097/01.ju.0001009372.61513.54.06.
- Grajales V, Duan Z, Tan W, Contieri R, Myers A, Zhao H, Giordano S, Williams S, Kamat A. MP24-20 IMPACT OF MENTAL HEALTH ILLNESS ON ADHERENCE TO SURVEILLANCE AND TREATMENT GUIDELINES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. Journal Of Urology 2024, 211: e401. DOI: 10.1097/01.ju.0001008860.46052.c4.20.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. PD30-08 ELUCIDATING THE RESPONSE RATES TO CONTINUED BACILLUS CALMETTE-GUERIN (BCG) IN PATIENTS WITH BCG EXPOSED BLADDER CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN. Journal Of Urology 2024, 211: e627. DOI: 10.1097/01.ju.0001008848.77629.6f.08.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. MP16-08 CHALLENGING THE PARADIGM OF “BCG UNRESPONSIVE” BLADDER CANCER: DOES ADDITIONAL BCG HAVE AN EFFECT? Journal Of Urology 2024, 211: e242. DOI: 10.1097/01.ju.0001008640.01272.9d.08.
- Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. MP16-06 THE INTERNATIONAL BLADDER CANCER GROUP INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER (IBCG IR-NMIBC) SCORING SYSTEM PREDICTS THE NEED FOR INTERVENTION FOR PATIENTS ON ACTIVE SURVEILLANCE. Journal Of Urology 2024, 211: e241. DOI: 10.1097/01.ju.0001008640.01272.9d.06.
- Annapureddy D, Taylor J, Howard J, Woldu S, Lotan Y, Tan W, Kamat A, McElree I, Packiam V, O'Donnell M, Facundo D, Li R, Yim K, Preston M, Harrington S, Dyer E, Raman J, Black A, Black P, Kanabur P, Lerner S, Roumiguié M, Steinberg G, Huang W. ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER. Urologic Oncology Seminars And Original Investigations 2024, 42: s52-s53. DOI: 10.1016/j.urolonc.2024.01.160.
- Taylor J, Annapureddy D, Howard J, Woldu S, Lotan Y, Tan W, Kamat A, McElree I, Packiam V, O'Donnell M, Davaro F, Li R, Yim K, Preston M, Harrington S, Dyer E, Raman J, Black A, Black P, Kanabur P, Lerner S, Roumiguié M, Steinberg G, Huang W. NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT. Urologic Oncology Seminars And Original Investigations 2024, 42: s49. DOI: 10.1016/j.urolonc.2024.01.152.
- Contieri R, Tan W, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. A0742 The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance. European Urology 2024, 85: s1717. DOI: 10.1016/s0302-2838(24)01313-7.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. A0739 Challenging the paradigm of BCG unresponsive bladder cancer: Does additional BCG have an effect? European Urology 2024, 85: s1712-s1713. DOI: 10.1016/s0302-2838(24)01310-1.
- Myers A, Tan W, de Groot J, Westney O, Kamat A. ‘Case of the Month’ from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA: ependymoma of the urinary bladder. BJU International 2024, 134: 45-47. PMID: 38379218, DOI: 10.1111/bju.16302.
- Contieri R, Tan W, Grajales V, Hensley P, Martini A, Bree K, Myers A, Nogueras‐Gonzalez G, Navai N, Dinney C, Guo C, Kamat A. Influence of lamina propria invasion extension on T1 high‐grade non‐muscle‐invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU International 2024, 133: 733-741. PMID: 38374533, DOI: 10.1111/bju.16293.
- Tan W, O'Donnell M, Li R, Kamat A, Packiam V. Reply to Wen-Wei Sung’s Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531–534. European Urology Oncology 2024, 7: 164-165. DOI: 10.1016/j.euo.2023.10.009.
- Lobo N, Duan Z, Sood A, Tan W, Grajales V, Contieri R, Lindskrog S, Dyrskjøt L, Zhao H, Giordano S, Williams S, Bree K, Kamat A. Association of Age with Non–muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities? European Urology Oncology 2024 PMID: 38302322, DOI: 10.1016/j.euo.2024.01.011.
- Grajales V, Contieri R, Tan W, Flores M, Schultz M, Pinochet R, Bustamante A, Kamat A, Fernández M. Comparative Analysis of Very Reduced vs Full Dose BCG Treatment for High-Risk Non-Muscle Invasive Bladder Cancer: A Contemporary Experience from Chile. Bladder Cancer 2023, 9: 327-334. PMID: 38994240, PMCID: PMC11165921, DOI: 10.3233/blc-230047.
- Hudson J, Cruickshank M, Quinton R, Aucott L, Wu F, Grossmann M, Bhasin S, Snyder P, Ellenberg S, Travison T, Brock G, Gianatti E, van der Schouw Y, Emmelot-Vonk M, Giltay E, Hackett G, Ramachandran S, Svartberg J, Hildreth K, Antonic K, Tenover J, Tan H, Ho Chee Kong C, Tan W, Marks L, Ross R, Schwartz R, Manson P, Roberts S, Skovsager Andersen M, Velling Magnussen L, Aceves-Martins M, Gillies K, Hernández R, Oliver N, Dhillo W, Bhattacharya S, Brazzelli M, Jayasena C. Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis. The Lancet Healthy Longevity 2023, 4: e561-e572. PMID: 37804846, DOI: 10.1016/s2666-7568(23)00169-1.
- Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. Reply by Authors. Journal Of Urology 2023, 210: 770-770. PMID: 37622536, DOI: 10.1097/ju.0000000000003639.02.
- Khetrapal P, Wong J, Tan W, Rupasinghe T, Tan W, Williams S, Boorjian S, Wijburg C, Parekh D, Wiklund P, Vasdev N, Khan M, Guru K, Catto J, Kelly J. Corrigendum to “Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials” [Eur Urol. 2023;84:393–405]. European Urology 2023, 84: e98-e99. PMID: 37562989, DOI: 10.1016/j.eururo.2023.06.023.
- Contieri R, Hensley P, Tan W, Grajales V, Bree K, Nogueras-Gonzalez G, Lee B, Navai N, Dinney C, Kamat A. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. European Urology Oncology 2023, 6: 590-596. PMID: 37558542, DOI: 10.1016/j.euo.2023.07.012.
- Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance. Journal Of Urology 2023, 210: 763-770. PMID: 37535836, DOI: 10.1097/ju.0000000000003639.
- Contieri R, Grajales V, Tan W, Martini A, Sood A, Hensley P, Bree K, Lobo N, Nogueras‐Gonzalez G, Guo C, Navai N, Dinney C, Kamat A. Impact of age >70 years on oncological outcomes in patients with non‐muscle‐invasive bladder cancer treated with Bacillus Calmette–Guérin. BJU International 2023, 133: 63-70. PMID: 37442564, PMCID: PMC10787034, DOI: 10.1111/bju.16127.
- Tan W, McElree I, Davaro F, Steinberg R, Bree K, Navai N, Dinney C, O'Donnell M, Li R, Kamat A, Packiam V. Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. European Urology Oncology 2023, 6: 531-534. PMID: 37468392, DOI: 10.1016/j.euo.2023.06.011.
- Tan W, Hall E, Kamat A, Kelly J. Clinical trial design for non-muscle-invasive bladder cancer. Nature Reviews Urology 2023, 20: 575-576. PMID: 37328547, DOI: 10.1038/s41585-023-00789-0.
- Heer R, Tan W, Gravestock P, Vadiveloo T, Lewis R, Penegar S, Vale L, MacLennan G, Hall E, Team P. Reply to Arnulf Stenzl, Morgan Rouprêt, J. Alfred Witjes, Paolo Gontero. High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. Eur Urol 2023;83:193–4. European Urology 2023, 85: 309-312. PMID: 37330372, DOI: 10.1016/j.eururo.2023.05.040.
- Tan W, Grajales V, Bree K, Li R, Nogueras‐Gonzalez G, Navai N, Dinney C, Kamat A. Bacillus Calmette–Guérin (BCG) unresponsive non‐muscle‐invasive bladder cancer: are the subgroups equal? BJU International 2023, 132: 384-386. PMID: 37246493, DOI: 10.1111/bju.16087.
- Tan W, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes. European Urology Open Science 2023, 53: 16-22. PMID: 37441349, PMCID: PMC10334230, DOI: 10.1016/j.euros.2023.04.013.
- Khetrapal P, Wong J, Tan W, Rupasinghe T, Tan W, Williams S, Boorjian S, Wijburg C, Parekh D, Wiklund P, Vasdev N, Khan M, Guru K, Catto J, Kelly J. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials. European Urology 2023, 84: 393-405. PMID: 37169638, DOI: 10.1016/j.eururo.2023.04.004.
- Contieri R, Tan W, Grajales V, Bree K, Hensley P, Guo C, Navai N, Dinney C, Kamat A. MP63-15 T1 SUB-STAGING IS ASSOCIATED WITH WORSE ONCOLOGICAL OUTCOMES FOR PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN OR IMMEDIATE RADICAL CYSTECTOMY. Journal Of Urology 2023, 209: e877. DOI: 10.1097/ju.0000000000003321.15.
- Contieri R, Grajales V, Tan W, Bree K, Hensley P, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. MP63-11 ADVANCED AGE (>70 YEARS) DOES NOT AFFECT ONCOLOGICAL OUTCOMES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH ADEQUATE BACILLUS CALMETTE-GUERIN: A COMPETING RISK ANALYSIS FROM a TERTIARY CARE CENTER. Journal Of Urology 2023, 209: e875. DOI: 10.1097/ju.0000000000003321.11.
- Contieri R, Hensley P, Tan W, Grajales V, Bree K, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. MP63-06 BACILLUS CALMETTE-GUERIN VS IMMEDIATE RADICAL CYSTECTOMY IN EAU DEFINED VERY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. Journal Of Urology 2023, 209: e873. DOI: 10.1097/ju.0000000000003321.06.
- Lobo N, Sood A, Duan Z, Tan W, Grajales V, Lindskrog S, Dyrskjøt L, Aarhus, Denmark, Zhao H, Giordano S, Williams S, Kamat A. PD29-05 ASSOCIATION OF AGE WITH NON-MUSCLE INVASIVE BLADDER CANCER: A BIOLOGICAL BASIS FOR EPIDEMIOLOGICAL DISPARITIES? Journal Of Urology 2023, 209: e826. DOI: 10.1097/ju.0000000000003315.05.
- Tan W, Ahmad A, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Tan W, Cohen D, Volanis D, Kamat A, Kelly J. PD29-01 THE HEMATURIA CANCER RISK SCORE: A VALIDATION STUDY DEMONSTRATING REDUCTION IN THE NUMBER NEEDED TO INVESTIGATE WHILE PRESERVING FIDELITY OF CANCER DETECTION. Journal Of Urology 2023, 209: e824. DOI: 10.1097/ju.0000000000003315.01.
- Grajales V, Duan Z, Tan W, Contieri R, Zhao H, Giordano S, Williams S, Kamat A. MP54-14 MENTAL HEALTH ILLNESS IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER. DOES BCG PLAY A ROLE? Journal Of Urology 2023, 209: e759. DOI: 10.1097/ju.0000000000003307.14.
- Tan W, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo C, Navai N, Dinney C, Kamat A. PD13-12 BLADDER SPARING TREATMENT IN PATIENTS WITH BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: AN ANALYSIS OF LONG-TERM SURVIVAL OUTCOMES. Journal Of Urology 2023, 209: e410. DOI: 10.1097/ju.0000000000003260.12.
- Tan W, Tan M, Alhalabi O, Campbell M, Kamat A, Gao J. Evolving systemic management of urothelial cancers. Current Opinion In Oncology 2023, 35: 186-199. PMID: 36966497, DOI: 10.1097/cco.0000000000000942.
- Ta A, Olphert J, Tan W, Alkhamees M, Shaw G, Sridhar A, Kelly J. V016 Technique and outcomes from prostate capsule-sparing during robotic male cystectomy. European Urology 2023, 83: s1918-s1919. DOI: 10.1016/s0302-2838(23)01358-1.
- Contieri R, Hensley P, Grajales V, Tan W, Bree K, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. A0722 Bacillus calmette-guerin vs immediate radical cystectomy in eau defined very high-risk non-muscle invasive bladder cancer patients. European Urology 2023, 83: s1023-s1024. DOI: 10.1016/s0302-2838(23)00766-2.
- Contieri R, Tan W, Grajales V, Bree K, Hensley P, Guo C, Navai N, Dinney C, Kamat A. A0607 T1 substaging is associated with worse oncological outcomes for patients treated with Bacillus Calmette-Guerin or immediate radical cystectomy. European Urology 2023, 83: s865. DOI: 10.1016/s0302-2838(23)00653-x.
- Lobo N, Sood A, Duan Z, Tan W, Grajales V, Lindskrog S, Dyrskjøt L, Zhao H, Giordano S, Williams S, Kamat A. A0605 Association of age with non-muscle-invasive bladder cancer: A biological basis for epidemiological disparities? European Urology 2023, 83: s863. DOI: 10.1016/s0302-2838(23)00651-6.
- Tan W, Ahmad A, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Tan W, Cohen D, Volanis D, Kamat A, Kelly J. A0269 The hematuria cancer risk score: A validation study demonstrating reduction in the number needed to investigate while preserving fidelity of cancer detection. European Urology 2023, 83: s385-s386. DOI: 10.1016/s0302-2838(23)00318-4.
- Tan W, Bello A, Alvarez C, Guerrero-Ramos F, González-Padilla D, Nzeh C, de la Morena J, de Torres I, Hendricksen K, Goizueta F, Del Álamo J, Chiancone F, Fedelini P, Poggio M, Porpiglia F, Rodríguez V, Torres J, Wilby D, Robinson R, Sousa-Escandón A, Mata J, Moreno J, Molina F, Semino M, Stemberger A, Escudero J, Redorta J, Tan W. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E. Bladder Cancer 2022, 8: 379-393. PMID: 38994184, PMCID: PMC11181696, DOI: 10.3233/blc-220026.
- Tan W, Mustard C, Kelly J, team H. Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak’s Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003. European Urology 2022, 83: e48-e49. PMID: 36456403, DOI: 10.1016/j.eururo.2022.11.006.
- Tan W, Kelly J, team H. Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini’s Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003. European Urology 2022, 83: e29-e30. PMID: 36272948, DOI: 10.1016/j.eururo.2022.10.009.
- Tan W, Koelker M, Campain N, Cole A, Labban M, Mossanen M, Barod R, Kibel A, Chang S, Bex A, Trinh Q. Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy. European Urology Focus 2022, 9: 333-335. PMID: 36241545, DOI: 10.1016/j.euf.2022.09.018.
- Leow J, Tan W, Tan W, Tan T, Chan V, Tikkinen K, Kamat A, Sengupta S, Meng M, Shariat S, Roupret M, Decaestecker K, Vasdev N, Chong Y, Enikeev D, Giannarini G, Ficarra V, Teoh J, Collaborators O. A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond. Frontiers In Surgery 2022, 9: 879774. PMID: 36268209, PMCID: PMC9577485, DOI: 10.3389/fsurg.2022.879774.
- Tan W, Ta A, Kelly J. Robotic surgery: getting the evidence right. The Medical Journal Of Australia 2022, 217: 391-393. PMID: 36183333, PMCID: PMC9828009, DOI: 10.5694/mja2.51726.
- Weyne E, Tan W, Kelly J, Sridhar A. Robotic Intracorporeal Neobladder: UCLH Experience. 2022, 681-686. DOI: 10.1007/978-3-031-00363-9_60.
- Tan W, Ta A, Sridhar A, Kelly J. Organ‐sparing radical cystectomy: improving functional outcomes. Trends In Urology & Men's Health 2022, 13: 7-10. DOI: 10.1002/tre.875.
- Tan W, Prendergast A, Ackerman C, Yogeswaran Y, Cresswell J, Mariappan P, Phull J, Hunter-Campbell P, Lazarowicz H, Mishra V, Rane A, Davies M, Warburton H, Cooke P, Mostafid H, Wilby D, Mills R, Issa R, Kelly J. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. European Urology 2022, 83: 497-504. PMID: 35999119, DOI: 10.1016/j.eururo.2022.08.003.
- Hensley P, Lobo N, Bree K, Tan W, Gontero P, Williams S, Guo C, Giannarini G, Dyrskjøt L, Kamat A. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale D’Urologie Journal 2022, 3: 245-257. DOI: 10.48083/rvzv1144.
- Tan W, Steinberg G, Witjes J, Li R, Shariat S, Roupret M, Babjuk M, Bivalacqua T, Psutka S, Williams S, Cookson M, Palou J, Kamat A. Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. European Urology Oncology 2022, 5: 505-516. PMID: 35718695, DOI: 10.1016/j.euo.2022.05.005.
- Hudson J, Cruickshank M, Quinton R, Aucott L, Aceves-Martins M, Gillies K, Bhasin S, Snyder P, Ellenberg S, Grossmann M, Travison T, Gianatti E, van der Schouw Y, Emmelot-Vonk M, Giltay E, Hackett G, Ramachandran S, Svartberg J, Hildreth K, Antonic K, Brock G, Tenover J, Tan H, Kong C, Tan W, Marks L, Ross R, Schwartz R, Manson P, Roberts S, Andersen M, Magnussen L, Hernández R, Oliver N, Wu F, Dhillo W, Bhattacharya S, Brazzelli M, Jayasena C. Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. The Lancet Healthy Longevity 2022, 3: e381-e393. PMID: 35711614, PMCID: PMC9184259, DOI: 10.1016/s2666-7568(22)00096-4.
- Cimadamore A, Teoh J, DI Trapani E, Krajewski W, Tan W, Mori K, Del Giudice F, Carrion D, Moschini M. A gender-related dichotomy in bladder cancer. Minerva Urologica E Nefrologica 2022, 74: 376-378. PMID: 35607787, DOI: 10.23736/s2724-6051.22.04954-0.
- Stemberger A, Tan W, Bello A, Alvarez J, Guerrero-Ramos F, González-Padilla D, Nzeh C, de la Morena J, de Torres I, Hendricksen K, Díaz-Goizueta F, Del Alamo J, Chiancone F, Fedelini P, Poggio M, Porpiglia F, Rodríguez V, Torres J, Wilby D, Robinson R, Sousa-Escandón A, León-Mata J, Moreno J, Molina F, Semino M, Calleja-Escudero J, Redorta J, Tan W. MP54-15 A MULTICENTER STUDY OF 2-YEAR OUTCOMES FOLLOWING HYPERTHERMIA THERAPY WITH MITOMYCIN C IN TREATING BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: RECIRCULANT HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY. Journal Of Urology 2022, 207: e932. DOI: 10.1097/ju.0000000000002633.15.
- Kadhim H, Ang K, Tan W, Nathan A, Pavan N, Mazzon G, Al-Kadhi O, Di G, Dinneen E, Briggs T, Kelkar A, Rajan P, Nathan S, Kelly J, Sooriakumaran P, Sridhar A. Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy. Journal Of Robotic Surgery 2022, 16: 1419-1426. PMID: 35192106, DOI: 10.1007/s11701-022-01383-z.
- Zhao H, Chan V, Castellani D, Chan E, Ong W, Peng Q, Moschini M, Krajewski W, Pradere B, Ng C, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan W, Kelly J, Shariat S, Witjes J, Teoh J. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Frontiers In Surgery 2021, 8: 775527. PMID: 34888347, PMCID: PMC8649716, DOI: 10.3389/fsurg.2021.775527.
- Zhao H, Chan V, Castellani D, Chan E, Ong W, Peng Q, Moschini M, Krajewski W, Pradere B, Ng C, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan W, Kelly J, Shariat S, Witjes J, Teoh J. 1459 Intravesical Chemohyperthermia Versus Bacillus Calmette-Guerin Instillation for Intermediate- And High-Risk Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. British Journal Of Surgery 2021, 108: znab259.955. DOI: 10.1093/bjs/znab259.955.
- Tan W, Leow J, Marchese M, Sridhar A, Hellawell G, Mossanen M, Teoh J, Fowler S, Colquhoun A, Cresswell J, Catto J, Trinh Q, Kelly J, Section of Oncology O. Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit. European Urology Open Science 2021, 33: 1-10. PMID: 34723215, PMCID: PMC8546928, DOI: 10.1016/j.euros.2021.08.005.
- Tan W, Leow J, Marchese M, Sridhar A, Hellawell G, Mossanen M, Teoh J, Fowler S, Colquhoun A, Cresswell J, Catto J, Trinh Q, Kelly J. PD59-10 FACTORS ASSOCIATED WITH HIGH-QUALITY SURGERY FOLLOWING RADICAL CYSTECTOMY: ANALYSIS OF THE BRITISH ASSOCIATION OF UROLOGICAL SURGEONS (BAUS) CYSTECTOMY AUDIT. Journal Of Urology 2021, 206: e1057-e1058. DOI: 10.1097/ju.0000000000002096.10.
- Abozaid M, Tan W, Khetrapal P, Baker H, Duncan J, Sridhar A, Briggs T, Selim M, Abdallah M, Elmahdy A, Elserafy F, Kelly J. Recovery of health‐related quality of life in patients undergoing robot‐assisted radical cystectomy with intracorporeal diversion. BJU International 2021, 129: 72-79. PMID: 34092021, DOI: 10.1111/bju.15505.
- Chan V, Tan W, Asif A, Ng A, Gbolahan O, Dinneen E, To W, Kadhim H, Premchand M, Burton O, Koe J, Wang N, Leow J, Giannarini G, Vasdev N, Shariat S, Enikeev D, Ng C, Teoh J. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis. Cancers 2021, 13: 3274. PMID: 34208888, PMCID: PMC8268689, DOI: 10.3390/cancers13133274.
- Albisinni S, Moschini M, Di Trapani E, Soria F, Mari A, Aziz A, Teoh J, Laukhtina E, Mori K, D’Andrea D, Carrion D, Krajewski W, Abufaraj M, Cimadamore A, Tan W, Flippot R, Khalifa J, Gonsette K, Pradere B. Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers. World Journal Of Urology 2021, 40: 1317-1323. PMID: 34076754, DOI: 10.1007/s00345-021-03746-x.
- Tan W, Leow J, Marchese M, Sridhar A, Hellawell G, Mossanen M, Teoh J, Fowler S, Colquhoun A, Cresswell J, Catto J, Trinh Q, Kelly J. P0827 Defining factors associated with high-quality surgery following radical cystectomy: Analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit. European Urology 2021, 79: s1151. DOI: 10.1016/s0302-2838(21)01202-1.
- Zhao H, Chan V, Castellani D, Chan E, Ong W, Peng Q, Moschini M, Krajewski W, Pradere B, Ng C, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan W, Kelly J, Shariat S, Witjes J, Teoh J. P0773 Intravesical chemohyperthermia versus bacillus calmette-guerin instillation for intermediate- and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis. European Urology 2021, 79: s1068-s1069. DOI: 10.1016/s0302-2838(21)01148-9.
- Chan V, Tan W, Leow J, Tan W, Ong W, Chiu P, Gurung P, Pirola G, Orecchia L, Liew M, Lee H, Wang Y, Chen I, Castellani D, Wroclawski M, Mayor N, Sathianathen N, Braga I, Liu Z, Moon D, Tikkinen K, Kamat A, Meng M, Ficarra V, Giannarini G, Teoh J. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic. World Journal Of Urology 2021, 39: 4295-4303. PMID: 34031748, PMCID: PMC8143063, DOI: 10.1007/s00345-021-03734-1.
- Tan W, Marchese M, Paciotti M, Nguyen D, Cone E, Mossanen M, Webster J, Barod R, Bex A, Kibel A, Chang S, Trinh Q. Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urologica E Nefrologica 2021, 73: 404-406. PMID: 33781018, DOI: 10.23736/s2724-6051.20.04197-1.
- Tan W, Kelly J. Is delay to radical cystectomy following BCG failure oncologically safe? Nature Reviews Urology 2021, 18: 323-324. PMID: 33772157, DOI: 10.1038/s41585-021-00457-1.
- Tan W, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, Pal R, Fowler W, Heer R, Elajnaf M, Douglas-Moore J, Griffiths T, Voss J, Wilby D, Al Kadhi O, Noel J, Vasdev N, McKay A, Ahmad I, Abu-Nayla I, Lamb B, Hill G, Narahari K, Kynaston H, Yousuf A, Kusuma V, Cresswell J, Cooke P, Chakravarti A, Barod R, Bex A, Kelly J, group O. Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes. European Urology Open Science 2021, 25: 39-43. PMID: 33458711, PMCID: PMC7796655, DOI: 10.1016/j.euros.2021.01.005.
- Tan W, Wong A, Mahmalji W, Raza A. Is there still a role for digital rectal examination in the prostate cancer diagnostic pathway in the COVID-19 and post COVID-19 era? The Aging Male 2021, 24: 92-94. PMID: 34319201, DOI: 10.1080/13685538.2020.1786047.
- Woldu S, Ng C, Loo R, Slezak J, Jacobsen S, Tan W, Kelly J, Lough T, Darling D, van Kessel K, de Jong J, van Criekinge W, Shariat S, Hiar A, Brown S, Boorjian S, Barocas D, Svatek R, Lotan Y. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. Journal Of Urology 2020, 205: 1387-1392. PMID: 33356483, DOI: 10.1097/ju.0000000000001550.
- Mortezavi A, Crippa A, Edeling S, Pokupic S, Dell’Oglio P, Montorsi F, D'Hondt F, Mottrie A, Decaestecker K, Wijburg C, Collins J, Kelly J, Tan W, Sridhar A, John H, Canda A, Schwentner C, Rönmark E, Wiklund P, Hosseini A. Morbidity and mortality after robot‐assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group. BJU International 2020, 127: 585-595. PMID: 33058469, PMCID: PMC8246851, DOI: 10.1111/bju.15274.
- Tan W, Marchese M, Sridhar A, Hellawell G, Mossanen M, Fowler S, Colquhoun A, Kelly J, Trinh Q. PT415 Defining factors associated with quality surgery following radical cystectomy: Analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit. European Urology Open Science 2020, 19: e2284. DOI: 10.1016/s2666-1683(20)34149-5.
- Abozaid M, Tan W, Khetrapal P, Baker H, Selim M, Abdallah M, Mahdy A, Elserafy F, Kelly J. 1104 Prospective evaluation of health related quality of life after robotic radical cystectomy with intracorporeal diversion. European Urology Open Science 2020, 19: e1641. DOI: 10.1016/s2666-1683(20)33695-8.
- Tan W, Chiancone F, Fedelini P, Boormans J, De Jong J, Wilby D, Robinson R, Poggio M, Escudero J, Goizueta F, Plata A, Vögeli T, Escandón A, Nzeh C, De La Morena J, Moreno J, Guerrero F, Torres J, Hendricksen K. 776 Intravesical chemohyperthermia (HIVEC-E) in BCG unresponsive non-muscle invasive bladder cancer patients: Oncological outcomes of a multi-centre European registry. European Urology Open Science 2020, 19: e1181-e1182. DOI: 10.1016/s2666-1683(20)33376-0.
- Paciotti M, Nguyen D, Lander A, Harrison S, Tan W, Von Landenberg N, Lughezzani G, Buffi N, Chang S, Trinh Q. 596 Rates and predictors of conversion to open surgery during laparoscopic and robotic nephrectomy. European Urology Open Science 2020, 19: e928-e929. DOI: 10.1016/s2666-1683(20)33199-2.
- Ahmed Y, Hussein A, May P, Ahmad B, Khan A, Benkowski J, Durrani A, Khan S, Kozlowski J, Saar M, Wijburg C, Richstone L, Wagner A, Yuh B, Redorta J, Dasgupta P, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Pini G, Schanne F, Mottrie A, Rha K, Hemal A, Stockle M, Kelly J, Tan W, Maatman T, Poulakis V, Kaouk J, Canda A, Balbay M, Wiklund P, Guru K. Quality of surgical care can impact survival in patients with bladder cancer after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. African Journal Of Urology 2020, 26: 22. DOI: 10.1186/s12301-020-00031-y.
- Tan W, Wang Y, Trinh Q, Preston M, Kelly J, Hrouda D, Kibel A, Krasnow R, Liu J, Chung B, Chang S, Mossanen M. Delayed blood transfusion is associated with mortality following radical cystectomy. Scandinavian Journal Of Urology 2020, 54: 290-296. PMID: 32538224, DOI: 10.1080/21681805.2020.1777195.
- Mukherjee S, Sinha R, Mandal S, Tan W. Primary Urethral Tuberculosis With Urethrocutaneous Fistula in Association With Balanitis Xerotica Obliterans. Urology 2020, 141: e20-e21. PMID: 32325139, DOI: 10.1016/j.urology.2020.04.035.
- Tan W, Kelly J. Editorial Comment. Journal Of Urology 2020, 204: 56-57. PMID: 32282283, DOI: 10.1097/ju.0000000000000786.02.
- Berg S, Tully K, Sahraoui A, Tan W, Krimphove M, Marchese M, Lipsitz S, Noldus J, Trinh Q. Inequity in selective referral to high-volume hospitals for genitourinary malignancies. Urologic Oncology Seminars And Original Investigations 2020, 38: 582-589. PMID: 32217041, DOI: 10.1016/j.urolonc.2020.02.013.
- Tan W, Teo C, Chan D, Ang K, Heinrich M, Feber A, Sarpong R, Williams N, Brew‐Graves C, Ng C, Kelly J, Khetrapal P, Sridhar A, Baker H, Ocampo F, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Heeney E, Green K, Evans S, Rogers M, Dann A, Cook J, Cornwell M, Mills R, Knight H, Maher S, Rane A, Thomas S, Reyner S, Vallejera G, Adeniran P, Masood S, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Srirangam S, Mistry R, Chadwick J, Cocks S, Hull R, Loftus A, Dawson L, Roberts H, Main C, Jain S, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Hicks J, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, Sinclair A, Storr E, Cogley L, Natale S, Lovegrove W, Smith S, Smith K, Hewitt D, Sriram R, Atkinson K, Royle L, Madine J, MacLean K, Walsh J, Guerdette A, Hill M, Payne D, Power A, Cannon J, Devereaux L, Thompson A, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Wardle H, Wilson D, Bayles A, Pelluri S, Pati J, Gherman A, Scott C, Madaan S, Taylor J, Edmunds E, Moore J, Rees A, Williams S, Caddy S, Dukes S, Goffe A, Buckhorn K, Nichols L, Acher P, Baillie K, Middleton K, Proctor C, Cresswell J, Chilvers A, Cain M, Vaux A, Watson D, Bradfield S, Gregory H, Mostafid H, Kehoe L, Drakeley S, Davies J, Williamson L, Krishnan R, Lunt N, Hill P, Burns H, Townley B, Wilkinson L, Wassall H, Sinclair A, Hunt J, Holbrook B, Stancombe L, Morrison J, Vankoutrik L, Misra S, Fossey G, Richards A, Mcdonald K, Henderson A, Fennelly R, Tribbeck M, Ames K, Borwell J, Kotze M, Beesley K, Rennie K, Porter T, Gipson A, Piper L, Bailey L, Chrisopoulou A, Slevin K, McCartin F, Warburton H, Hathaway‐Lees S, Whetton K, Delves G, Day A, Bankole T, Broadhead S, Malde S, Oblak M, Ellis D, Bishara S, Barias‐Lara T, Donkov I, Thatcher H, Morris H, Culmsee C, Menzies A, Bartlett C, Cutting C, O'Brien N, Jannapureddy R, Kelkar A, Fitzgerald J, Longhurst S, Worth C, Peracha A, Mzazi S, Poile C, Griffiths L, Cook A, Barber N, Brar N, Alty A, Zelhof B, Blades R. Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach. BJU International 2020, 125: 669-678. PMID: 31975539, PMCID: PMC7318301, DOI: 10.1111/bju.15008.
- Mukherjee S, Sinha R, Mandal S, Tan W. Spontaneous Ureterocutaneous Fistula Secondary to Obstructed Ureteric Stone. Urology 2020, 138: e5-e7. PMID: 31958535, DOI: 10.1016/j.urology.2020.01.013.
- Tan W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, Kilbridge K, Vale J, Khoubehi B, Kibel A, Sun M, Chang S, Sammon J. Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis. Urologic Oncology Seminars And Original Investigations 2019, 38: 74.e13-74.e20. PMID: 31864937, DOI: 10.1016/j.urolonc.2019.11.008.
- Cox E, Saramago P, Kelly J, Porta N, Hall E, Tan W, Sculpher M, Soares M. Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT Trial. Clinical Genitourinary Cancer 2019, 18: e418-e442. PMID: 32144049, PMCID: PMC7427321, DOI: 10.1016/j.clgc.2019.12.004.
- Jubber I, Shariat S, Conroy S, Tan W, Gordon P, Lotan Y, Messing E, Stenzl A, Rhijn B, Kelly J, Catto J, Cumberbatch M. Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European Urology 2019, 77: 583-598. PMID: 31791622, DOI: 10.1016/j.eururo.2019.10.010.
- Tan W, Tan W, Inman B. PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis. Bladder Cancer 2019, 5: 211-223. PMID: 31867425, PMCID: PMC6919639, DOI: 10.3233/blc-190238.
- Sridhar A, Tan W, Rawlinson A, Pavan N, Gu D, Shaw G, Nathan S, Rajan P, Kelkar A, Allen C, Sooriakumaran P, Briggs T. PE38 Determining adverse risk factors for urinary continence recovery after robotic radical prostatectomy and methods to enable early recovery. European Urology Open Science 2019, 18: e2602. DOI: 10.1016/s1569-9056(19)32724-1.
- Mortezavi A, Edeling S, Pokupic S, Dell’oglio P, Montorsi F, D'hondt F, Mottrie A, Decaestecker K, Wijburg C, Kelly J, Tan W, Sridhar A, John H, Canda E, Schwentener C, Rönmark E, Wiklund P, Hosseini A. PE61 Survival outcome after robotic assisted radical cystectomy with intracorporal urinary diversion in elderly patients. European Urology Open Science 2019, 18: e2636. DOI: 10.1016/s1569-9056(19)32747-2.
- Moschini M, Zamboni S, Soria F, Mathieu R, Xylinas E, Tan W, Kelly J, Simone G, Meraney A, Krishna S, Konety B, Mattei A, Baumeister P, Mordasini L, Montorsi F, Briganti A, Gallina A, Stabile A, Sanchez-Salas R, Cathelineau X, Rink M, Necchi A, Karakiewicz P, Rouprêt M, Koupparis A, Kassouf W, Scherr D, Ploussard G, Boorjian S, Lotan Y, Sooriakumaran P, Shariat S. Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes. Journal Of Clinical Medicine 2019, 8: 1192. PMID: 31395826, PMCID: PMC6722857, DOI: 10.3390/jcm8081192.
- Tan W, Krimphove M, Cole A, Marchese M, Berg S, Lipsitz S, Löppenberg B, Nabi J, Abdollah F, Choueiri T, Kibel A, Sooriakumaran P, Trinh Q. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer. Clinical Genitourinary Cancer 2019, 17: e1060-e1068. PMID: 31303561, DOI: 10.1016/j.clgc.2019.06.008.
- Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D`Andrea D, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Krishna S, Konety B, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Koupparis A, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M, Urologists U. Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU International 2019, 124: 656-664. PMID: 31055865, DOI: 10.1111/bju.14791.
- Thompson J, Sridhar A, Tan W, Freeman A, Haider A, Allen C, Moore C, Orczyk C, Mazzon G, Khetrapal P, Shaw G, Rajan P, Mohammed A, Briggs T, Nathan S, Kelly J, Sooriakumaran P. Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound. Journal Of Urology 2019, 201: 1134-1143. PMID: 30730409, DOI: 10.1097/ju.0000000000000135.
- Mossanen M, Krasnow R, Zlatev D, Tan W, Preston M, Trinh Q, Kibel A, Sonpavde G, Schrag D, Chung B, Chang S. Examining the relationship between complications and perioperative mortality following radical cystectomy: a population‐based analysis. BJU International 2019, 124: 40-46. PMID: 30499636, DOI: 10.1111/bju.14636.
- Tan* W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Waisbrod S, Hermanns T, Sasieni P, Kelly J. PD66-05 DEVELOPMENT AND VALIDATION OF A HEMATURIA CANCER RISK SCORE TO IDENTIFY PATIENTS AT RISK OF HARBOURING CANCER. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000557467.24162.d4.
- Tan* W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, Kilbridge K, Kibel A, Sun M, Chang S, Sammon J. PD46-02 DELAYED NEPHRECTOMY HAS COMPARABLE LONG-TERM OVERALL SURVIVAL TO IMMEDIATE NEPHRECTOMY FOR CT1A RENAL CELL CARCINOMA: A RETROSPECTIVE COHORT STUDY. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000556746.68596.8e.
- Zamboni* S, Soria F, Mathieu R, Xylinas E, D'Andrea D, Abufaraj M, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Krishna S, Konety B, Montorsi F, Briganti A, Mattei A, Baumeister P, Antonelli A, Simeone C, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Perry M, Rowe E, Koupparis A, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M. MP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555883.61031.df.
- Tan* W, Hendricksen K, Wilby D, Nzeh C, Goizueta J, Vilmar W, Bello A, Sousa A, Morena J, Pontones J, Guerrero F, Kalchev I, Frank E, Boormans J. PD13-10 ONCOLOGICAL OUTCOMES OF BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH POSTOPERATIVE CHEMOHYPERTHERMIA: A MULTICENTRE EUROPEAN RETROSPECTIVE ANALYSIS. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555390.06113.0b.
- Tan W, Kelly J, Tan W. The investigation of haematuria and bladder cancer. Trends In Urology & Men's Health 2019, 10: 25-27. DOI: 10.1002/tre.685.
- Tan W, Teo C, Chan D, Heinrich M, Feber A, Sarpong R, Allan J, Williams N, Brew‐Graves C, Ng C, Kelly J, Khetrapal P, ridhar A, Baker H, Ocampo F, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Heeney E, Green K, Evans S, Rogers M, Dann A, Cook J, Cornwell M, Mills R, Knight H, Maher S, Rane A, Thomas S, Reyner S, Vallejera G, Adeniran P, Masood S, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Srirangam S, Mistry R, Chadwick J, Cocks S, Hull R, Loftus A, Dawson L, Roberts H, Main C, Jain S, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Hicks J, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, inclair A, Storr E, Cogley L, Natale S, Lovegrove W, Smith S, Smith K, Hewitt D, Sriram R, Atkinson K, Royle L, Madine J, MacLean K, Walsh J, Guerdette M, Hill M, Payne D, Power A, Cannon J, Devereaux L, Thompson A, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Wardle H, Wilson D, Bayles A, Pelluri S, Pati J, Gherman A, Scott C, Madaan S, Taylor A, Edmunds E, Moore J, Rees A, Williams S, Caddy S, Dukes S, Goffe A, Buckhorn K, Nichols L, Acher P, Baillie K, Middleton K, Proctor C, Cresswell J, Chilvers A, Cain M, Vaux A, Watson D, Bradfield S, Gregory H, Mostafid H, Kehoe L, Drakeley S, Davies A, Williamson L, Krishnan R, Lunt N, Hill P, Burns H, Townley B, Wilkinson L, Wassall H, Hunt J, Holbrook B, Stancombe L, Morrison J, Vankoutrik L, Misra S, Fossey G, Richards A, Mcdonald K, Henderson A, Fennelly R, Tribbeck M, Ames K, Borwell J, Kotze M, Beesley K, Rennie K, Porter T, Gipson A, Piper L, Bailey L, Chrisopoulou A, Slevin K, McCartin F, Warburton H, Hathaway‐Lees S, Whetton K, Delves G, Day A, Bankole T, Broadhead S, Malde S, Oblak M, Ellis D, Bishara S, Barias‐Lara T, Donkov I, Thatcher H, Morris M, Culmsee C, Menzies H, Bartlett C, Cutting C, O'Brien N, Jannapureddy R, Kelkar A, Fitzgerald J, Longhurst S, Worth C, Peracha M, Mzazi S, Poile C, Griffiths L, Cook A, Barber N, Brar N, lty A, Zelhof B, Blades R. Mixed‐methods approach to exploring patients’ perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance. BJU International 2019, 124: 408-417. PMID: 30694612, PMCID: PMC6767410, DOI: 10.1111/bju.14690.
- Tan W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Hermanns T, Waisbrod S, Sasieni P, Kelly J. 182 Development and external validation of the haematuria cancer risk score to identify patient at risk of harbouring cancer. European Urology Open Science 2019, 18: e247-e249. DOI: 10.1016/s1569-9056(19)30179-4.
- Zamboni S, Soria F, Mathieu R, Xylinas E, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Konety B, Antonelli A, Simeone C, Baumeister P, Mattei A, Montorsi F, Briganti A, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M, Urologists U. 843 Comparative effectiveness of robotic assisted and open radical cystectomy in contemporary cohorts of bladder cancer patients: An international multicenter collaboration. European Urology Open Science 2019, 18: e1139-e1140. DOI: 10.1016/s1569-9056(19)30821-8.
- Tan W, Krimphove M, Cole A, Berg S, Marchese M, Lipsitz S, Loppenberg B, Nabi J, Abdollah F, Choueiri T, Kibel A, Sooriakumaran P, Trinh Q. 222 Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer. European Urology Open Science 2019, 18: e294-e295. DOI: 10.1016/s1569-9056(19)30214-3.
- Mossanen M, Wang Y, Szymaniak J, Tan W, Huynh M, Preston M, Trinh Q, Sonpavde G, Schrag D, Kibel A, Chang S. 705 Evaluating the cost of surveillance for non-muscle invasive bladder cancer: An economic analysis based on risk categories. European Urology Open Science 2019, 18: e942. DOI: 10.1016/s1569-9056(19)30685-2.
- Tan W, Berg S, Cole A, Krimphove M, Marchese M, Lipsitz S, Nabi J, Sammon J, Choueiri T, Kibel A, Sun M, Chang S, Trinh Q. 1056 Comparing long-term outcomes following radical and partial nephrectomy for cT1 renal cell carcinoma in young and healthy individuals. European Urology Open Science 2019, 18: e1423-e1424. DOI: 10.1016/s1569-9056(19)31027-9.
- Tan W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, Kilbridge K, Kibel A, Sun M, Chang S, Sammon J. 913 Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A retrospective cohort study. European Urology Open Science 2019, 18: e1235-e1236. DOI: 10.1016/s1569-9056(19)30887-5.
- Berg S, Pucheril D, Sahraoui A, Tan W, Krimphove M, Marchese M, Lipsitz S, Noldus J, Kibel A, Trinh Q. PT392 Barriers to selective referral of genitourinary cancers to high- vs. low-volume hospitals. European Urology Open Science 2019, 18: e2202-e2203. DOI: 10.1016/s1569-9056(19)31592-1.
- Tan W, Teo C, Chan D, Heinrich M, Feber A, Sarpong R, Allan J, Williams N, Brew-Graves C, Ng C, Kelly J. 227 Mix methods approach to determine patients’ perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy for bladder cancer surveillance. European Urology Open Science 2019, 18: e303. DOI: 10.1016/s1569-9056(19)30219-2.
- Tan W, Berg S, Cole A, Krimphove M, Marchese M, Lipsitz S, Nabi J, Sammon J, Choueiri T, Kibel A, Sun M, Chang S, Trinh Q. Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals. JNCI Cancer Spectrum 2019, 3: pkz003. PMID: 31360891, PMCID: PMC6649692, DOI: 10.1093/jncics/pkz003.
- Tan W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Waisbrod S, Hermanns T, Sasieni P, Kelly J, Khetrapal P, Baker H, Sridhar A, Lamb B, Ocampo F, McBain H, Baillie K, Middleton K, Watson D, Knight H, Maher S, Rane A, Pathmanathan B, Harmathova A, Hellawell G, Pelluri S, Pati J, Cossons A, Scott C, Madaan S, Bradfield S, Wakeford N, Dann A, Cook J, Cornwell M, Mills R, Thomas S, Reyner S, Vallejera G, Adeniran P, Masood S, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Heeney E, Green K, Evans S, Rogers M, Gupwell K, Whiteley S, Brown A, McGrath J, Lunt N, Hill P, Sinclair A, Paredes‐Guerra A, Holbrook B, Ong E, Wardle H, Wilson D, Bayles A, Fennelly R, Tribbeck M, Ames K, Davies M, Taylor J, Edmunds E, Moore J, Mckinley S, Nolan T, Speed A, Tunnicliff A, Fossey G, Williams A, George M, Hutchins I, Einosas R, Richards A, Henderson A, Appleby B, Kehoe L, Gladwell L, Drakeley S, Davies J, Krishnan R, Roberts H, Main C, Jain S, Dumville J, Wilkinson N, Taylor J, Thomas F, Goulden K, Vinod C, Green E, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Srirangam S, Rees A, Williams S, Dukes S, Goffe A, Dawson L, Mistry R, Chadwick J, Cocks S, Hull R, Loftus A, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Hicks J, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, Sinclair A, Storr E, Cogley L, Natale S, Lovegrove W, Slack K, Nash D, Smith K, Walsh J, Guerdette A, Hill M, Payne D, Taylor B, Sinclair E, Perry M, Debbarma M, Hewitt D, Sriram R, Power A, Cannon J, Devereaux L, Thompson A, Atkinson K, Royle L, Madine J, MacLean K, Sarpong R, Brew‐Graves C, Williams N. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer. Journal Of Internal Medicine 2019, 285: 436-445. PMID: 30521125, PMCID: PMC6446724, DOI: 10.1111/joim.12868.
- Tan W, Kelly J. Is experience with extracorporeal urinary diversion following robotic assisted radical cystectomy necessary before transitioning to intracorporeal urinary diversion? Translational Andrology And Urology 2018, 0: s735-s737. PMID: 30687611, PMCID: PMC6323277, DOI: 10.21037/tau.2018.08.22.
- Mossanen M, Wang Y, Szymaniak J, Tan W, Huynh M, Preston M, Trinh Q, Sonpavde G, Kibel A, Chang S. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World Journal Of Urology 2018, 37: 2059-2065. PMID: 30446799, DOI: 10.1007/s00345-018-2550-x.
- Moschini M, Soria F, Mathieu R, Xylinas E, D'Andrea D, Tan W, Kelly J, Simone G, Tuderti G, Meraney A, Krishna S, Konety B, Zamboni S, Baumeister P, Mattei A, Briganti A, Montorsi F, Galucci M, Rink M, Karakiewicz P, Rouprêt M, Aziz A, Perry M, Rowe E, Koupparis A, Kassouf W, Scherr D, Ploussard G, Boorjian S, Sooriakumaran P, Shariat S, Urologists U. Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy. Urologic Oncology Seminars And Original Investigations 2018, 37: 179.e1-179.e7. PMID: 30446442, DOI: 10.1016/j.urolonc.2018.10.012.
- Kelly J, Tan W, Porta N, Mostafid H, Huddart R, Protheroe A, Bogle R, Blazeby J, Palmer A, Cresswell J, Johnson M, Brough R, Madaan S, Andrews S, Cruickshank C, Burnett S, Maynard L, Hall E, Investigators O. BOXIT—A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004). European Urology 2018, 75: 593-601. PMID: 30279015, DOI: 10.1016/j.eururo.2018.09.020.
- Tan W, Panchal A, Buckley L, Devall A, Loubière L, Pope A, Feneley M, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths T, Page T, Hodgson D, Datta S, Billingham L, Kelly J. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial. European Urology 2018, 75: 63-71. PMID: 30274699, DOI: 10.1016/j.eururo.2018.09.005.
- Wong Y, Joshi K, Khetrapal P, Ismail M, Reading J, Sunderland M, Georgiou A, Furness A, Aissa A, Ghorani E, Oakes T, Uddin I, Tan W, Feber A, McGovern U, Swanton C, Freeman A, Marafioti T, Briggs T, Kelly J, Powles T, Peggs K, Chain B, Linch M, Quezada S. Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment. Journal Of Experimental Medicine 2018, 215: 2748-2759. PMID: 30257862, PMCID: PMC6219732, DOI: 10.1084/jem.20181003.
- Tan W, Kelly J. Intravesical device-assisted therapies for non-muscle-invasive bladder cancer. Nature Reviews Urology 2018, 15: 667-685. PMID: 30254383, DOI: 10.1038/s41585-018-0092-z.
- Thompson J, Sridhar A, Tan W, Khetrapal P, Mazzon G, Shaw G, Rajan P, Alkadhi O, Di G, Briggs T, Nathan S, Sooriakumaran P, Kelly J. PE35 Pathologic findings and MRI concordance at salvage RARP for local recurrence following high-intensity focused ultrasound (HIFU) therapy: High rate of adverse prognostic features and poor sensitivity of MRI. European Urology Open Science 2018, 17: e2296. DOI: 10.1016/s1569-9056(18)32698-8.
- Tan W, Sarpong R, Khetrapal P, Rodney S, Mostafid H, Cresswell J, Watson D, Rane A, Hicks J, Hellawell G, Davies M, Srirangam S, Dawson L, Payne D, Williams N, Brew‐Graves C, Feber A, Kelly J, Sridhar A, Lamb B, Ocampo F, McBain H, Baillie K, Middleton K, Knight H, Maher S, Pathmanathan B, Harmathova A, Pelluri S, Pati J, Cossons A, Scott C, Madaan S, Bradfield S, Wakeford N, Dann, Cook J, Cornwell M, Mills R, Thomas, Reyner S, Vallejera G, Adeniran P, Masood S, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Hheeney E, Green K, Evans S, Rogers M, Gupwell K, ley S, Brown A, McGrath J, Lunt N, Hill P, inclair A, Paredes‐Guerra A, Holbrook B, Ong E, Wardle H, Wilson D, Bayles A, Fennelly R, Tribbeck M, Ames K, Taylor J, Edmunds E, Moore J, Mckinley S, Nolan T, peed A, Tunnicliff A, Fossey G, Williams A, George M, Hutchins I, Einosas R, Richards A, Henderson A, Appleby B, Kehoe L, Gladwell L, Drakeley S, Davies J, Krishnan R, Roberts H, Main C, Jain S, Dumville J, Wilkinson N, Taylor J, Thomas F, Goulden K, Vinod C, Green E, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Rees A, Williams S, Dukes S, Goffe A, Mistry R, Chadwick J, Cocks S, Hull R, oftus A, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, Storr E, Cogley L, Natale S, Lovegrove W, Slack K, Nash D, Smith K, Walsh J, Guerdette A, Hill M, Taylor B, Sinclair E, Perry M, Debbarma M, Hewitt D, Sriram R, Power A, Cannon J, Devereaux L, Thompson A, Atkinson K, Royle L, Madine J, MacLean K. Does urinary cytology have a role in haematuria investigations? BJU International 2018, 123: 74-81. PMID: 30003675, PMCID: PMC6334509, DOI: 10.1111/bju.14459.
- Tan W, Tan W, Tan M, Khetrapal P, Dong L, deWinter P, Feber A, Kelly J. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treatment Reviews 2018, 69: 39-52. PMID: 29902678, DOI: 10.1016/j.ctrv.2018.05.012.
- Tan W, Sarpong R, Khetrapal P, Rodney S, Mostafid H, Cresswell J, Hicks J, Rane A, Henderson A, Watson D, Cherian J, Williams N, Brew-Graves C, Feber A, Kelly J, Collaborators D. Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria? Journal Of Urology 2018, 200: 973-980. PMID: 29702097, PMCID: PMC6179963, DOI: 10.1016/j.juro.2018.04.065.
- Khetrapal P, Lee M, Tan W, Dong L, de Winter P, Feber A, Kelly J. The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review. Cancer Treatment Reviews 2018, 66: 56-63. PMID: 29684744, DOI: 10.1016/j.ctrv.2018.03.007.
- Tan W, Feber A, Sarpong R, Khetrapal P, Rodney S, Jalil R, Mostafid H, Cresswell J, Hicks J, Rane A, Henderson A, Watson D, Cherian J, Williams N, Brew-Graves C, Kelly J, collaborators O. Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. European Urology 2018, 74: 10-14. PMID: 29653885, DOI: 10.1016/j.eururo.2018.03.008.
- Tan W, Feber A, Dong L, Sarpong R, Rodney S, Khetrapal P, de Winter P, Jalil R, Williams N, Brew-Graves C, Kelly J, group D. MP63-15 CAN RENAL TRACT ULTRASOUND REPLACE CT UROGRAPHY FOR THE EVALUATION OF MICROSCOPIC HEMATURIA? RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY. Journal Of Urology 2018, 199: e846-e847. DOI: 10.1016/j.juro.2018.02.2038.
- Hussein A, May P, Jing Z, Ahmed Y, Wijburg C, Richstone L, Wagner A, Redorta J, Badani K, Khan H, Saar M, Stockle M, Dasgupta P, Kawa O, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Pini G, Schanne F, Poulakis V, Weizer A, Kelly J, Tan W, Maatman T, Canda A, Mottrie A, Kaouk J, Yuh B, Rha K, Hemal A, Peak T, Wiklund P, Guru K. MP49-01 OUTCOMES OF INTRACORPOREAL URINARY DIVERSION AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM. Journal Of Urology 2018, 199: e665. DOI: 10.1016/j.juro.2018.02.1592.
- Tan W, Feber A, Dong L, Sarpong R, Rodney S, Khetrapal P, de Winter P, Jalil R, Williams N, Brew-Graves C, Kelly J, group D. MP06-06 DOES URINARY CYTOLOGY HAVE A ROLE IN HEMATURIA INVESTIGATIONS? RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY (DETECT I). Journal Of Urology 2018, 199: e54. DOI: 10.1016/j.juro.2018.02.198.
- Tan W, Feber A, Dong L, Sarpong R, Rodney S, Khetrapal P, de Winter P, Jalil R, Williams N, Brew-Graves C, Kelly J, group D. MP06-08 WHO SHOULD BE EVALUATED FOR HEMATURIA? A COMPARISON OF INTERNATIONAL GUIDELINES. Journal Of Urology 2018, 199: e54-e55. DOI: 10.1016/j.juro.2018.02.200.
- Hussein A, May P, Jing Z, Ahmed Y, Wijburg C, Canda A, Balbay M, Dasgupta P, Khan M, Kawa O, Hosseini A, Menon M, Peabody J, Kelly J, Mottrie A, Gaboardi F, Pini G, Kaouk J, Hemal A, Redorta J, Stockle M, Saar M, Yuh B, Badani K, Tan W, Poulakis V, Weizer A, Wiklund P, Guru K. MP49-02 COMPARING EXTRA-CORPOREAL AND INTRA-CORPOREAL NEOBLADDERS AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM. Journal Of Urology 2018, 199: e665-e666. DOI: 10.1016/j.juro.2018.02.1593.
- Tan W, Tan W. Urinary biomarker for the detection of recurrence following non- muscle invasive bladder cancer: are we there yet? Translational Andrology And Urology 2018, 7: s109-s110. PMID: 29644175, PMCID: PMC5881187, DOI: 10.21037/tau.2017.12.18.
- Tan W, Feber A, Sarpong R, Khetrapal P, Rodney S, Jalil R, Dong L, Rezaee S, Williams N, Brew-Graves C, Kelly J. 910 Can ultrasound renal tract replace CT intravenous urogram in patients investigated for non-visible haematuria? Results of the DETECT I study. European Urology Open Science 2018, 17: e1294. DOI: 10.1016/s1569-9056(18)31741-x.
- Khetrapal P, Dong L, Wong Y, Tan W, Rodney S, Lamb B, Briggs T, Thompson J, Sridhar A, Kelly J, Feber A. 1079 Using plasma cell-free DNA mutations to monitor patients for micro-metastatic bladder cancer after radical cystectomy. European Urology Open Science 2018, 17: e1527. DOI: 10.1016/s1569-9056(18)31902-x.
- Tan W, Feber A, Sarpong R, Jalil R, Khetrapal P, Rodney P, Dong L, Rezaee S, Wiliams N, Brew-Graves C, Kelly J. 1012 What is the role of urinary cytology as part of haematuria investigations? Results of a prospective observational study (DETECT I). European Urology Open Science 2018, 17: e1426. DOI: 10.1016/s1569-9056(18)31837-2.
- Hussein A, May P, Jing Z, Ahmed Y, Wijburg C, Canda A, Dasgupta P, Khan M, Menon M, Peabody J, Hosseini A, Kelly J, Mottrie A, Kaouk J, Hemal A, Wiklund P, Guru K, Collaborators, Wagner A, Saar M, Stockle M, Redorta J, Richstone L, Badani K, Scherr D, Khan H, Gaboardi F, Rha K, Kawa O, Tan W, Schanne F, Polakis V, Weizer A, Maatman T, Pini G, Peak T, Kibel A, Yuh B. Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Journal Of Urology 2017, 199: 1302-1311. PMID: 29275112, DOI: 10.1016/j.juro.2017.12.045.
- Tan W, Tan M, Lamb B, Sridhar A, Mohammed A, Baker H, Nathan S, Briggs T, Tan M, Kelly J. Intracorporeal robot‐assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains. BJU International 2017, 121: 632-639. PMID: 29124853, DOI: 10.1111/bju.14073.
- Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than OthersKhetrapal P, Tan W, Kelly J. Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than Others. European Urology 2017, 73: 383-384. PMID: 29174579, DOI: 10.1016/j.eururo.2017.11.004.
- Tan W, Feber A, Dong L, Sarpong R, Rezaee S, Rodney S, Khetrapal P, de Winter P, Ocampo F, Jalil R, Williams N, Brew-Graves C, Kelly J. DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells. BMC Cancer 2017, 17: 767. PMID: 29141603, PMCID: PMC5688623, DOI: 10.1186/s12885-017-3758-7.
- Tan W, Sridhar A, Kelly J. Male Robot-Assisted Radical Cystectomy. 2017, 195-205. DOI: 10.1007/978-3-319-65864-3_16.
- Hussein A, May P, Ahmed Y, Saar M, Wijburg C, Richstone L, Wagner A, Wilson T, Yuh B, Redorta J, Dasgupta P, Kawa O, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Pini G, Schanne F, Mottrie A, Rha K, Hemal A, Stockle M, Kelly J, Tan W, Maatman T, Poulakis V, Kaouk J, Canda A, Balbay M, Wiklund P, Guru K. Development of a patient and institutional‐based model for estimation of operative times for robot‐assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU International 2017, 120: 695-701. PMID: 28620985, DOI: 10.1111/bju.13934.
- Dong L, Khetrapal P, Rodney S, Tan W, Rezaee S, Winter P, Kelly J, Feber A. Abstract 5702: A targeted re-sequencing assay for molecular profiling of somatic mutations from plasma cell-free dna (cfdna) for bladder cancers. Cancer Research 2017, 77: 5702-5702. DOI: 10.1158/1538-7445.am2017-5702.
- Khetrapal P, Tan W, Lamb B, Tan M, Baker H, Thompson J, Sridhar A, Kelly J, Briggs T. The Role of Robotics in the Invasive Management of Bladder Cancer. Current Urology Reports 2017, 18: 57. PMID: 28634646, DOI: 10.1007/s11934-017-0706-7.
- Rodney S, Tanic M, Barrett J, Amy W, de Winter P, Tan W, Khetrapal P, Dong L, Rezaee S, Freeman A, Nigam R, Malone P, Muneer A, Beck S, Feber A, Kelly J. Multiregion sequencing of penile cancer to reveal distinct patterns of heterogeneous actionable mutations. Journal Of Clinical Oncology 2017, 35: 4518-4518. DOI: 10.1200/jco.2017.35.15_suppl.4518.
- Tan W, Buckley L, Devall A, Loubiére L, Pope A, Feneley M, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths L, Page T, Hodgson D, Datta S, Billingham L, Kelly J. PD19-08 RADIOFREQUENCY-INDUCED THERMO-CHEMOTHERAPY EFFECT (RITE) PLUS MITOMYCIN VERSUS A SECOND COURSE OF BACILLUS CALMETTE-GUÉRIN (BCG) OR INSTITUTIONAL STANDARD IN PATIENTS WITH RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER FOLLOWING INDUCTION OR MAINTENANCE BCG THERAPY (HYMN): A OPEN-LABEL, MULTICENTRE, PHASE III RANDOMISED CONTROLLED TRIAL. Journal Of Urology 2017, 197: e367-e368. DOI: 10.1016/j.juro.2017.02.881.
- Tan W, Palou J, Kelly J, Group H. MP15-18 SAFETY AND TOLERABILITY ANALYSIS OF HYPERTHERMIC INTRAVESICAL MITOMYCIN TO MITOMYCIN ALONE IN HIVEC I AND HIVEC II: AN ANALYSIS OF 307 PATIENTS. Journal Of Urology 2017, 197: e177. DOI: 10.1016/j.juro.2017.02.503.
- Zahran M, Abozaid M, Taha D, Lamb B, Sridhar A, Tan W, Almekaty K, Hefnawy A, Ali-El-Dein. B, Kelly J. MP10-17 HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION. OPEN VERSUS ROBOTIC ASSISTED TECHNIQUES. Journal Of Urology 2017, 197: e114-e115. DOI: 10.1016/j.juro.2017.02.345.
- May P, Dexter F, Hussein A, Ahmed Y, Hosseini A, Wiklund P, Peabody J, Ho-Rha K, Richstone L, Khan S, Wijburg C, Saar M, Canda A, Kaouk J, Wagner A, Yuh B, Redorta J, Balbay M, Maatman T, Smits G, Menon M, Stoeckle M, Kawa O, Hemal A, Pini G, Gaboardi F, Mottrie A, Kelly J, Tan W, Schanne F, Weizer A, Peak T, Guru K. MP92-05 CALCULATING SURGICAL TIME FOR ROBOT-ASSISTED RADICAL CYSTECTOMY BASED ON PATIENT RELATED METRICS & INSTITUTIONAL EXPERIENCE: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM. Journal Of Urology 2017, 197: e1227-e1228. DOI: 10.1016/j.juro.2017.02.2866.
- Khetrapal P, Dong L, Wong Y, Tan W, Rodney S, Lamb B, Sridhar A, Briggs T, Kelly J, Feber A. MP44-13 MOLECULAR TRACKING OF BLADDER CANCERUSING MUTATIONS DETECTED IN PLASMA CELL-FREE DNA THROUGH RADICAL CYSTECTOMY AND CHEMOTHERAPY. Journal Of Urology 2017, 197: e568. DOI: 10.1016/j.juro.2017.02.1344.
- Tan W, Buckley L, Devall A, Loubière L, Pope A, Feneley M, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths L, Page T, Hodgson D, Datta S, Bilingham L, Kelly J. 665 Radiofrequency-induced thermo-chemotherapy effect plus mitomycin versus a second course of bacillus Calmette-Guérin (BCG) or institutional standard in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance BCG therapy (HYMN): A phase III, open-label, randomised controlled trial. European Urology Open Science 2017, 16: e1156-e1157. DOI: 10.1016/s1569-9056(17)30720-0.
- Tan W, Palou J, Kelly J. 662 Safety and tolerability analysis of hyperthermic intravesical mitomycin to mitomycin alone in HIVEC I and HIVEC II: An interim analysis of 307 patients. European Urology Open Science 2017, 16: e1150-e1151. DOI: 10.1016/s1569-9056(17)30717-0.
- Tan W, Lamb B, Tan M, Sridhar A, Mohammed A, Baker H, Briggs T, Tan M, Kelly J. 588 Enhanced recovery enhances reduction of length of stay in patients treated with robotic assisted radical cystectomy with intracorporeal urinary diversion. European Urology Open Science 2017, 16: e1022. DOI: 10.1016/s1569-9056(17)30645-0.
- Tan W, Lamb B, Sridhar A, Briggs T, Kelly J. A Comprehensive Guide to Perioperative Management and Operative Technique for Robotic Cystectomy with Intracorporeal Urinary Diversion. Urologia Journal 2017, 84: 71-78. PMID: 28256704, DOI: 10.5301/uj.5000224.
- Feber A, Dhami P, Dong L, de Winter P, Tan W, Martínez-Fernández M, Paul D, Hynes-Allen A, Rezaee S, Gurung P, Rodney S, Mehmood A, Villacampa F, de la Rosa F, Jameson C, Cheng K, Zeegers M, Bryan R, James N, Paramio J, Freeman A, Beck S, Kelly J. UroMark—a urinary biomarker assay for the detection of bladder cancer. Clinical Epigenetics 2017, 9: 8. PMID: 28163793, PMCID: PMC5282868, DOI: 10.1186/s13148-016-0303-5.
- Tan W, Lamb B, Khetrapal P, Tan M, Tan M, Sridhar A, Cervi E, Rodney S, Busuttil G, Nathan S, Hines J, Shaw G, Mohammed A, Baker H, Briggs T, Klein A, Richards T, Kelly J. Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy. Journal Of Endourology 2017, 31: 141-148. PMID: 27901350, DOI: 10.1089/end.2016.0730.
- Hussein A, Saar M, May P, Wijburg C, Richstone L, Wagner A, Wilson T, Yuh B, Redorta J, Dasgupta P, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Mottrie A, Rha K, Hemal A, Stockle M, Kelly J, Maatman T, Canda A, Wiklund P, Guru K, Collaborators, Balbay M, Poulakis V, Woods M, Tan W, Kawa O, Pini G, Badani K, Ahmed Y. Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Journal Of Urology 2016, 197: 1427-1436. PMID: 27993668, DOI: 10.1016/j.juro.2016.12.048.
- Tan W, Khetrapal P, Tan W, Rodney S, Chau M, Kelly J. Robotic Assisted Radical Cystectomy with Extracorporeal Urinary Diversion Does Not Show a Benefit over Open Radical Cystectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. PLOS ONE 2016, 11: e0166221. PMID: 27820855, PMCID: PMC5098822, DOI: 10.1371/journal.pone.0166221.
- Feber A, Worth D, Chakravarthy A, de Winter P, Shah K, Arya M, Saqib M, Nigam R, Malone P, Tan W, Rodney S, Freeman A, Jameson C, Wilson G, Powles T, Beck S, Fenton T, Sharp T, Muneer A, Kelly J. CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma. Cancer Research 2016, 76: 4720-4727. PMID: 27325650, PMCID: PMC5302160, DOI: 10.1158/0008-5472.can-15-3134.
- Khetrapal P, Tan W, Lamb B, Nathan S, Briggs T, Shankar A, Ramachandran N, Freeman A, Mitra A, Kelly J. Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options. Clinical Genitourinary Cancer 2016, 15: 440-444. PMID: 28209455, DOI: 10.1016/j.clgc.2016.06.012.
- Tan W, Lamb B, Tan M, Ahmad I, Sridhar A, Nathan S, Hines J, Shaw G, Briggs T, Kelly J. In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion. European Urology Focus 2016, 3: 273-279. PMID: 28753745, DOI: 10.1016/j.euf.2016.06.002.
- Lamb B, Tan W, Eneje P, Bruce D, Jones A, Ahmad I, Sridhar A, Baker H, Briggs T, Hines J, Nathan S, Martin D, Stephens R, Kelly J. Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: A prospective cohort study. Urologic Oncology Seminars And Original Investigations 2016, 34: 417.e17-417.e23. PMID: 27197920, DOI: 10.1016/j.urolonc.2016.04.006.
- Tan W, Rodney S, Lamb B, Feneley M, Kelly J. Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treatment Reviews 2016, 47: 22-31. PMID: 27231966, DOI: 10.1016/j.ctrv.2016.05.002.
- Tan W, Tan M, Tan W, Gan S, Pathmanathan R, Tan H, Tan W. Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis: Case Report and Systematic Review of Literature. Clinical Genitourinary Cancer 2016, 14: e435-e439. PMID: 27067374, DOI: 10.1016/j.clgc.2016.03.007.
- Tan W, Sridhar A, Ellis G, Lamb B, Goldstraw M, Nathan S, Hines J, Cathcart P, Briggs T, Kelly J. Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes. Urologic Oncology Seminars And Original Investigations 2016, 34: 257.e1-257.e9. PMID: 26968561, DOI: 10.1016/j.urolonc.2016.02.010.
- Feber A, De Winter P, Dhami P, Martinez-Fernande M, Paul D, Hynes-Allen A, Tan W, Gurung P, Rodney S, Mehmood A, Jameson C, Paramio J, Bryan R, James N, Freeman A, Beck S, Kelly J. 293 UroMark - a highly multiplex biomarker for the detection of bladder cancer. European Urology Open Science 2016, 15: e293-e293a. DOI: 10.1016/s1569-9056(16)60295-6.
- Tan W, Lamb B, Kelly J. Evolution of the neobladder: A critical review of open and intracorporeal neobladder reconstruction techniques. Scandinavian Journal Of Urology 2016, 50: 95-103. PMID: 26882458, DOI: 10.3109/21681805.2016.1141318.
- Tan W, Lamb B, Kelly J. Complications of Radical Cystectomy and Orthotopic Reconstruction. Advances In Urology 2015, 2015: 323157. PMID: 26697063, PMCID: PMC4677163, DOI: 10.1155/2015/323157.
- Tan W, Sridhar A, Goldstraw M, Zacharakis E, Nathan S, Hines J, Cathcart P, Briggs T, Kelly J. Robot‐assisted intracorporeal pyramid neobladder. BJU International 2015, 116: 771-779. PMID: 26033321, DOI: 10.1111/bju.13189.
- Lamb B, Tan W, Rehman A, Nessa A, Cohen D, O'Neil J, Green J, Hines J. Is Prebiopsy MRI Good Enough to Avoid Prostate Biopsy? A Cohort Study Over a 1-Year Period. Clinical Genitourinary Cancer 2015, 13: 512-517. PMID: 26231912, DOI: 10.1016/j.clgc.2015.06.007.
- Feber A, Arya M, De Winter P, Muhammad S, Nigam R, Malone P, Tan W, Rodney S, Lechner M, Freeman A, Jameson C, Muneer A, Beck S, Kelly J. 702 Epigenomics of penile squamous cell carcinoma. European Urology Open Science 2015, 14: e702-e702a. DOI: 10.1016/s1569-9056(15)60694-7.
- Feber A, Arya M, de Winter P, Saqib M, Nigam R, Malone P, Tan W, Rodney S, Lechner M, Freeman A, Jameson C, Muneer A, Beck S, Kelly J. Epigenetics Markers of Metastasis and HPV-Induced Tumorigenesis in Penile Cancer. Clinical Cancer Research 2015, 21: 1196-1206. PMID: 25538261, PMCID: PMC4351916, DOI: 10.1158/1078-0432.ccr-14-1656.
- Tan W, Lamb B, Payne H, Hughes S, Green J, Lane T, Adshead J, Boustead G, Vasdev N. Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice. Clinical Genitourinary Cancer 2014, 13: e153-e158. PMID: 25510376, DOI: 10.1016/j.clgc.2014.11.006.
- Gurung P, Veerakumarasivam A, Williamson M, Counsell N, Douglas J, Tan W, Feber A, Crabb S, Short S, Freeman A, Powles T, Hoskin P, West C, Kelly J. Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle‐invasive bladder cancer. International Journal Of Cancer 2014, 136: 709-720. PMID: 24917520, DOI: 10.1002/ijc.29022.
- Tan W, De Winter P, Gurung P, Ip L, King K, Gewinner C, Freeman A, Bryan R, James N, Beck S, Kelly J, Feber A. 512 INPP4B knockdown confers cisplatin sensitivity in bladder cancer. European Urology Open Science 2014, 13: e512. DOI: 10.1016/s1569-9056(14)60504-2.
- Tan W, Low W, Ng C, Tan W, Tong S, Ho C, Khoo E, Lee G, Lee B, Lee V, Tan H. Efficacy and safety of long‐acting intramuscular testosterone undecanoate in aging men: a randomised controlled study. BJU International 2013, 111: 1130-1140. PMID: 23651425, DOI: 10.1111/bju.12037.
- Gurung P, Counsell N, Douglas J, Tan W, Feber A, Short S, Crabb S, West C, Hoskin P, Beltran L, Freeman A, Powles T, Kelly J. 58 DNA damage response (DDR) genes are predictive of response to radiotherapy for muscle invasive bladder cancer. European Urology Open Science 2013, 12: e58-e59. DOI: 10.1016/s1569-9056(13)60551-5.
- Feber A, Tan W, De Winter P, Freeman A, King K, Gurung P, Jameson C, Bryan R, James N, Beck S, Kelly J. 51 Epigenetic alterations associated with neo-adjuvant chemotherapy resistance in bladder cancer. European Urology Open Science 2013, 12: e51. DOI: 10.1016/s1569-9056(13)60544-8.
- Tan W, Ng C, Khoo E, Low W, Tan H. The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study). The Aging Male 2011, 14: 231-236. PMID: 22115177, DOI: 10.3109/13685538.2011.597463.
- Tan W. Biochemical Recurrence after Radical Radiotherapy for Localised Prostate Cancer — the Cardiff Experience. Clinical Oncology 2011, 23: s55. DOI: 10.1016/j.clon.2011.01.489.
- Tan W, Low W, Ng C, Khoo E, Ho E, Tan H. Overactive bladder (OAB) and its association with prostatic parameters. Journal Of Men's Health 2011, 8: s71-s74. DOI: 10.1016/s1875-6867(11)60026-2.
- Tan H, Khoo E, Ng C, Low W, Yap P, Tan W. 340 THE AGING MALES' SYMPTOMS' SCALE (AMS) - A GENERAL SCREENING INSTRUMENT FOR AGING MALES' HEALTH PROBLEM? European Urology Open Science 2007, 6: 107. DOI: 10.1016/s1569-9056(07)60339-x.
Departments and Programs
Titles
- Assistant Professor
Education & Training
- Fellow, Urologic OncologyUniversity of Texas MD Anderson Cancer Center
- Fellow, Robotic UrologyUniversity College London Hospitals
- Resident, UrologyLondon School of Surgery
- Non Degree ProgramRoyal College of Surgeons of England
- PhDUniversity College London
- MDCardiff University
- BScUniversity College London
Additional Information
Board Certifications
- Royal College of Surgeons of England, Urology (2022)
Publications
- Taylor J, Kamat A, O'Donnell M, Annapureddy D, Howard J, Tan W, McElree I, Davaro F, Yim K, Harrington S, Dyer E, Black A, Kanabur P, Roumiguié M, Lerner S, Black P, Raman J, Preston M, Steinberg G, Huang W, Li R, Packiam V, Woldu S, Lotan Y. Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer. BJU International 2024 PMID: 39183466, DOI: 10.1111/bju.16509.
- Li R, Hensley P, Gupta S, Al-Ahmadie H, Babjuk M, Black P, Brausi M, Bree K, Fernández M, Guo C, Horowitz A, Lamm D, Lerner S, Lotan Y, Mariappan P, McConkey D, Mertens L, Mir C, Ross J, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess P, Svatek R, Tan W, Taoka R, Buckley R, Kamat A. Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. European Urology 2024 PMID: 39183090, DOI: 10.1016/j.eururo.2024.08.001.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect? European Urology 2024 PMID: 38879371, DOI: 10.1016/j.eururo.2024.05.027.
- Tan W, Ta A, Sridhar A, Kelly J. Male Robot-Assisted Radical Cystectomy with Nerve Sparing Technique. 2024, 291-302. DOI: 10.1007/978-3-031-49428-4_23.
- Tan W, Ahmad A, Zhou Y, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Smith R, Khalifeh M, Tan W, Cohen D, Volanis D, Walter F, Sasieni P, Kamat A, Kelly J. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria. European Urology Oncology 2024 PMID: 38811250, DOI: 10.1016/j.euo.2024.05.005.
- Grajales V, Contieri R, Tan W, Tuke D, Akhverdiyeva L, Hwang H, Myers A, Kamat A. MP35-06 PICTURE PERFECT DIAGNOSES: EVALUATING UROLOGISTS' TUMOR IDENTIFICATION SKILLS: THE PROSPECTIVE TUMOR GRADING VISUAL ACCURACY (TRIVIA) STUDY. Journal Of Urology 2024, 211: e582. DOI: 10.1097/01.ju.0001009372.61513.54.06.
- Grajales V, Duan Z, Tan W, Contieri R, Myers A, Zhao H, Giordano S, Williams S, Kamat A. MP24-20 IMPACT OF MENTAL HEALTH ILLNESS ON ADHERENCE TO SURVEILLANCE AND TREATMENT GUIDELINES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. Journal Of Urology 2024, 211: e401. DOI: 10.1097/01.ju.0001008860.46052.c4.20.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. PD30-08 ELUCIDATING THE RESPONSE RATES TO CONTINUED BACILLUS CALMETTE-GUERIN (BCG) IN PATIENTS WITH BCG EXPOSED BLADDER CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN. Journal Of Urology 2024, 211: e627. DOI: 10.1097/01.ju.0001008848.77629.6f.08.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. MP16-08 CHALLENGING THE PARADIGM OF “BCG UNRESPONSIVE” BLADDER CANCER: DOES ADDITIONAL BCG HAVE AN EFFECT? Journal Of Urology 2024, 211: e242. DOI: 10.1097/01.ju.0001008640.01272.9d.08.
- Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. MP16-06 THE INTERNATIONAL BLADDER CANCER GROUP INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER (IBCG IR-NMIBC) SCORING SYSTEM PREDICTS THE NEED FOR INTERVENTION FOR PATIENTS ON ACTIVE SURVEILLANCE. Journal Of Urology 2024, 211: e241. DOI: 10.1097/01.ju.0001008640.01272.9d.06.
- Annapureddy D, Taylor J, Howard J, Woldu S, Lotan Y, Tan W, Kamat A, McElree I, Packiam V, O'Donnell M, Facundo D, Li R, Yim K, Preston M, Harrington S, Dyer E, Raman J, Black A, Black P, Kanabur P, Lerner S, Roumiguié M, Steinberg G, Huang W. ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER. Urologic Oncology Seminars And Original Investigations 2024, 42: s52-s53. DOI: 10.1016/j.urolonc.2024.01.160.
- Taylor J, Annapureddy D, Howard J, Woldu S, Lotan Y, Tan W, Kamat A, McElree I, Packiam V, O'Donnell M, Davaro F, Li R, Yim K, Preston M, Harrington S, Dyer E, Raman J, Black A, Black P, Kanabur P, Lerner S, Roumiguié M, Steinberg G, Huang W. NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT. Urologic Oncology Seminars And Original Investigations 2024, 42: s49. DOI: 10.1016/j.urolonc.2024.01.152.
- Contieri R, Tan W, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. A0742 The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance. European Urology 2024, 85: s1717. DOI: 10.1016/s0302-2838(24)01313-7.
- Myers A, Tan W, Grajales V, Hwang H, Bree K, Navai N, Lee B, Dinney C, Kamat A. A0739 Challenging the paradigm of BCG unresponsive bladder cancer: Does additional BCG have an effect? European Urology 2024, 85: s1712-s1713. DOI: 10.1016/s0302-2838(24)01310-1.
- Myers A, Tan W, de Groot J, Westney O, Kamat A. ‘Case of the Month’ from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA: ependymoma of the urinary bladder. BJU International 2024, 134: 45-47. PMID: 38379218, DOI: 10.1111/bju.16302.
- Contieri R, Tan W, Grajales V, Hensley P, Martini A, Bree K, Myers A, Nogueras‐Gonzalez G, Navai N, Dinney C, Guo C, Kamat A. Influence of lamina propria invasion extension on T1 high‐grade non‐muscle‐invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU International 2024, 133: 733-741. PMID: 38374533, DOI: 10.1111/bju.16293.
- Tan W, O'Donnell M, Li R, Kamat A, Packiam V. Reply to Wen-Wei Sung’s Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023;6:531–534. European Urology Oncology 2024, 7: 164-165. DOI: 10.1016/j.euo.2023.10.009.
- Lobo N, Duan Z, Sood A, Tan W, Grajales V, Contieri R, Lindskrog S, Dyrskjøt L, Zhao H, Giordano S, Williams S, Bree K, Kamat A. Association of Age with Non–muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities? European Urology Oncology 2024 PMID: 38302322, DOI: 10.1016/j.euo.2024.01.011.
- Grajales V, Contieri R, Tan W, Flores M, Schultz M, Pinochet R, Bustamante A, Kamat A, Fernández M. Comparative Analysis of Very Reduced vs Full Dose BCG Treatment for High-Risk Non-Muscle Invasive Bladder Cancer: A Contemporary Experience from Chile. Bladder Cancer 2023, 9: 327-334. PMID: 38994240, PMCID: PMC11165921, DOI: 10.3233/blc-230047.
- Hudson J, Cruickshank M, Quinton R, Aucott L, Wu F, Grossmann M, Bhasin S, Snyder P, Ellenberg S, Travison T, Brock G, Gianatti E, van der Schouw Y, Emmelot-Vonk M, Giltay E, Hackett G, Ramachandran S, Svartberg J, Hildreth K, Antonic K, Tenover J, Tan H, Ho Chee Kong C, Tan W, Marks L, Ross R, Schwartz R, Manson P, Roberts S, Skovsager Andersen M, Velling Magnussen L, Aceves-Martins M, Gillies K, Hernández R, Oliver N, Dhillo W, Bhattacharya S, Brazzelli M, Jayasena C. Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis. The Lancet Healthy Longevity 2023, 4: e561-e572. PMID: 37804846, DOI: 10.1016/s2666-7568(23)00169-1.
- Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. Reply by Authors. Journal Of Urology 2023, 210: 770-770. PMID: 37622536, DOI: 10.1097/ju.0000000000003639.02.
- Khetrapal P, Wong J, Tan W, Rupasinghe T, Tan W, Williams S, Boorjian S, Wijburg C, Parekh D, Wiklund P, Vasdev N, Khan M, Guru K, Catto J, Kelly J. Corrigendum to “Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials” [Eur Urol. 2023;84:393–405]. European Urology 2023, 84: e98-e99. PMID: 37562989, DOI: 10.1016/j.eururo.2023.06.023.
- Contieri R, Hensley P, Tan W, Grajales V, Bree K, Nogueras-Gonzalez G, Lee B, Navai N, Dinney C, Kamat A. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. European Urology Oncology 2023, 6: 590-596. PMID: 37558542, DOI: 10.1016/j.euo.2023.07.012.
- Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance. Journal Of Urology 2023, 210: 763-770. PMID: 37535836, DOI: 10.1097/ju.0000000000003639.
- Contieri R, Grajales V, Tan W, Martini A, Sood A, Hensley P, Bree K, Lobo N, Nogueras‐Gonzalez G, Guo C, Navai N, Dinney C, Kamat A. Impact of age >70 years on oncological outcomes in patients with non‐muscle‐invasive bladder cancer treated with Bacillus Calmette–Guérin. BJU International 2023, 133: 63-70. PMID: 37442564, PMCID: PMC10787034, DOI: 10.1111/bju.16127.
- Tan W, McElree I, Davaro F, Steinberg R, Bree K, Navai N, Dinney C, O'Donnell M, Li R, Kamat A, Packiam V. Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. European Urology Oncology 2023, 6: 531-534. PMID: 37468392, DOI: 10.1016/j.euo.2023.06.011.
- Tan W, Hall E, Kamat A, Kelly J. Clinical trial design for non-muscle-invasive bladder cancer. Nature Reviews Urology 2023, 20: 575-576. PMID: 37328547, DOI: 10.1038/s41585-023-00789-0.
- Heer R, Tan W, Gravestock P, Vadiveloo T, Lewis R, Penegar S, Vale L, MacLennan G, Hall E, Team P. Reply to Arnulf Stenzl, Morgan Rouprêt, J. Alfred Witjes, Paolo Gontero. High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation. Eur Urol 2023;83:193–4. European Urology 2023, 85: 309-312. PMID: 37330372, DOI: 10.1016/j.eururo.2023.05.040.
- Tan W, Grajales V, Bree K, Li R, Nogueras‐Gonzalez G, Navai N, Dinney C, Kamat A. Bacillus Calmette–Guérin (BCG) unresponsive non‐muscle‐invasive bladder cancer: are the subgroups equal? BJU International 2023, 132: 384-386. PMID: 37246493, DOI: 10.1111/bju.16087.
- Tan W, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes. European Urology Open Science 2023, 53: 16-22. PMID: 37441349, PMCID: PMC10334230, DOI: 10.1016/j.euros.2023.04.013.
- Khetrapal P, Wong J, Tan W, Rupasinghe T, Tan W, Williams S, Boorjian S, Wijburg C, Parekh D, Wiklund P, Vasdev N, Khan M, Guru K, Catto J, Kelly J. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials. European Urology 2023, 84: 393-405. PMID: 37169638, DOI: 10.1016/j.eururo.2023.04.004.
- Contieri R, Tan W, Grajales V, Bree K, Hensley P, Guo C, Navai N, Dinney C, Kamat A. MP63-15 T1 SUB-STAGING IS ASSOCIATED WITH WORSE ONCOLOGICAL OUTCOMES FOR PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN OR IMMEDIATE RADICAL CYSTECTOMY. Journal Of Urology 2023, 209: e877. DOI: 10.1097/ju.0000000000003321.15.
- Contieri R, Grajales V, Tan W, Bree K, Hensley P, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. MP63-11 ADVANCED AGE (>70 YEARS) DOES NOT AFFECT ONCOLOGICAL OUTCOMES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH ADEQUATE BACILLUS CALMETTE-GUERIN: A COMPETING RISK ANALYSIS FROM a TERTIARY CARE CENTER. Journal Of Urology 2023, 209: e875. DOI: 10.1097/ju.0000000000003321.11.
- Contieri R, Hensley P, Tan W, Grajales V, Bree K, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. MP63-06 BACILLUS CALMETTE-GUERIN VS IMMEDIATE RADICAL CYSTECTOMY IN EAU DEFINED VERY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. Journal Of Urology 2023, 209: e873. DOI: 10.1097/ju.0000000000003321.06.
- Lobo N, Sood A, Duan Z, Tan W, Grajales V, Lindskrog S, Dyrskjøt L, Aarhus, Denmark, Zhao H, Giordano S, Williams S, Kamat A. PD29-05 ASSOCIATION OF AGE WITH NON-MUSCLE INVASIVE BLADDER CANCER: A BIOLOGICAL BASIS FOR EPIDEMIOLOGICAL DISPARITIES? Journal Of Urology 2023, 209: e826. DOI: 10.1097/ju.0000000000003315.05.
- Tan W, Ahmad A, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Tan W, Cohen D, Volanis D, Kamat A, Kelly J. PD29-01 THE HEMATURIA CANCER RISK SCORE: A VALIDATION STUDY DEMONSTRATING REDUCTION IN THE NUMBER NEEDED TO INVESTIGATE WHILE PRESERVING FIDELITY OF CANCER DETECTION. Journal Of Urology 2023, 209: e824. DOI: 10.1097/ju.0000000000003315.01.
- Grajales V, Duan Z, Tan W, Contieri R, Zhao H, Giordano S, Williams S, Kamat A. MP54-14 MENTAL HEALTH ILLNESS IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER. DOES BCG PLAY A ROLE? Journal Of Urology 2023, 209: e759. DOI: 10.1097/ju.0000000000003307.14.
- Tan W, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo C, Navai N, Dinney C, Kamat A. PD13-12 BLADDER SPARING TREATMENT IN PATIENTS WITH BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: AN ANALYSIS OF LONG-TERM SURVIVAL OUTCOMES. Journal Of Urology 2023, 209: e410. DOI: 10.1097/ju.0000000000003260.12.
- Tan W, Tan M, Alhalabi O, Campbell M, Kamat A, Gao J. Evolving systemic management of urothelial cancers. Current Opinion In Oncology 2023, 35: 186-199. PMID: 36966497, DOI: 10.1097/cco.0000000000000942.
- Ta A, Olphert J, Tan W, Alkhamees M, Shaw G, Sridhar A, Kelly J. V016 Technique and outcomes from prostate capsule-sparing during robotic male cystectomy. European Urology 2023, 83: s1918-s1919. DOI: 10.1016/s0302-2838(23)01358-1.
- Contieri R, Hensley P, Grajales V, Tan W, Bree K, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. A0722 Bacillus calmette-guerin vs immediate radical cystectomy in eau defined very high-risk non-muscle invasive bladder cancer patients. European Urology 2023, 83: s1023-s1024. DOI: 10.1016/s0302-2838(23)00766-2.
- Contieri R, Tan W, Grajales V, Bree K, Hensley P, Guo C, Navai N, Dinney C, Kamat A. A0607 T1 substaging is associated with worse oncological outcomes for patients treated with Bacillus Calmette-Guerin or immediate radical cystectomy. European Urology 2023, 83: s865. DOI: 10.1016/s0302-2838(23)00653-x.
- Lobo N, Sood A, Duan Z, Tan W, Grajales V, Lindskrog S, Dyrskjøt L, Zhao H, Giordano S, Williams S, Kamat A. A0605 Association of age with non-muscle-invasive bladder cancer: A biological basis for epidemiological disparities? European Urology 2023, 83: s863. DOI: 10.1016/s0302-2838(23)00651-6.
- Tan W, Ahmad A, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Tan W, Cohen D, Volanis D, Kamat A, Kelly J. A0269 The hematuria cancer risk score: A validation study demonstrating reduction in the number needed to investigate while preserving fidelity of cancer detection. European Urology 2023, 83: s385-s386. DOI: 10.1016/s0302-2838(23)00318-4.
- Tan W, Bello A, Alvarez C, Guerrero-Ramos F, González-Padilla D, Nzeh C, de la Morena J, de Torres I, Hendricksen K, Goizueta F, Del Álamo J, Chiancone F, Fedelini P, Poggio M, Porpiglia F, Rodríguez V, Torres J, Wilby D, Robinson R, Sousa-Escandón A, Mata J, Moreno J, Molina F, Semino M, Stemberger A, Escudero J, Redorta J, Tan W. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E. Bladder Cancer 2022, 8: 379-393. PMID: 38994184, PMCID: PMC11181696, DOI: 10.3233/blc-220026.
- Tan W, Mustard C, Kelly J, team H. Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak’s Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003. European Urology 2022, 83: e48-e49. PMID: 36456403, DOI: 10.1016/j.eururo.2022.11.006.
- Tan W, Kelly J, team H. Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini’s Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003. European Urology 2022, 83: e29-e30. PMID: 36272948, DOI: 10.1016/j.eururo.2022.10.009.
- Tan W, Koelker M, Campain N, Cole A, Labban M, Mossanen M, Barod R, Kibel A, Chang S, Bex A, Trinh Q. Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy. European Urology Focus 2022, 9: 333-335. PMID: 36241545, DOI: 10.1016/j.euf.2022.09.018.
- Leow J, Tan W, Tan W, Tan T, Chan V, Tikkinen K, Kamat A, Sengupta S, Meng M, Shariat S, Roupret M, Decaestecker K, Vasdev N, Chong Y, Enikeev D, Giannarini G, Ficarra V, Teoh J, Collaborators O. A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond. Frontiers In Surgery 2022, 9: 879774. PMID: 36268209, PMCID: PMC9577485, DOI: 10.3389/fsurg.2022.879774.
- Tan W, Ta A, Kelly J. Robotic surgery: getting the evidence right. The Medical Journal Of Australia 2022, 217: 391-393. PMID: 36183333, PMCID: PMC9828009, DOI: 10.5694/mja2.51726.
- Weyne E, Tan W, Kelly J, Sridhar A. Robotic Intracorporeal Neobladder: UCLH Experience. 2022, 681-686. DOI: 10.1007/978-3-031-00363-9_60.
- Tan W, Ta A, Sridhar A, Kelly J. Organ‐sparing radical cystectomy: improving functional outcomes. Trends In Urology & Men's Health 2022, 13: 7-10. DOI: 10.1002/tre.875.
- Tan W, Prendergast A, Ackerman C, Yogeswaran Y, Cresswell J, Mariappan P, Phull J, Hunter-Campbell P, Lazarowicz H, Mishra V, Rane A, Davies M, Warburton H, Cooke P, Mostafid H, Wilby D, Mills R, Issa R, Kelly J. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. European Urology 2022, 83: 497-504. PMID: 35999119, DOI: 10.1016/j.eururo.2022.08.003.
- Hensley P, Lobo N, Bree K, Tan W, Gontero P, Williams S, Guo C, Giannarini G, Dyrskjøt L, Kamat A. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale D’Urologie Journal 2022, 3: 245-257. DOI: 10.48083/rvzv1144.
- Tan W, Steinberg G, Witjes J, Li R, Shariat S, Roupret M, Babjuk M, Bivalacqua T, Psutka S, Williams S, Cookson M, Palou J, Kamat A. Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. European Urology Oncology 2022, 5: 505-516. PMID: 35718695, DOI: 10.1016/j.euo.2022.05.005.
- Hudson J, Cruickshank M, Quinton R, Aucott L, Aceves-Martins M, Gillies K, Bhasin S, Snyder P, Ellenberg S, Grossmann M, Travison T, Gianatti E, van der Schouw Y, Emmelot-Vonk M, Giltay E, Hackett G, Ramachandran S, Svartberg J, Hildreth K, Antonic K, Brock G, Tenover J, Tan H, Kong C, Tan W, Marks L, Ross R, Schwartz R, Manson P, Roberts S, Andersen M, Magnussen L, Hernández R, Oliver N, Wu F, Dhillo W, Bhattacharya S, Brazzelli M, Jayasena C. Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. The Lancet Healthy Longevity 2022, 3: e381-e393. PMID: 35711614, PMCID: PMC9184259, DOI: 10.1016/s2666-7568(22)00096-4.
- Cimadamore A, Teoh J, DI Trapani E, Krajewski W, Tan W, Mori K, Del Giudice F, Carrion D, Moschini M. A gender-related dichotomy in bladder cancer. Minerva Urologica E Nefrologica 2022, 74: 376-378. PMID: 35607787, DOI: 10.23736/s2724-6051.22.04954-0.
- Stemberger A, Tan W, Bello A, Alvarez J, Guerrero-Ramos F, González-Padilla D, Nzeh C, de la Morena J, de Torres I, Hendricksen K, Díaz-Goizueta F, Del Alamo J, Chiancone F, Fedelini P, Poggio M, Porpiglia F, Rodríguez V, Torres J, Wilby D, Robinson R, Sousa-Escandón A, León-Mata J, Moreno J, Molina F, Semino M, Calleja-Escudero J, Redorta J, Tan W. MP54-15 A MULTICENTER STUDY OF 2-YEAR OUTCOMES FOLLOWING HYPERTHERMIA THERAPY WITH MITOMYCIN C IN TREATING BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: RECIRCULANT HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY. Journal Of Urology 2022, 207: e932. DOI: 10.1097/ju.0000000000002633.15.
- Kadhim H, Ang K, Tan W, Nathan A, Pavan N, Mazzon G, Al-Kadhi O, Di G, Dinneen E, Briggs T, Kelkar A, Rajan P, Nathan S, Kelly J, Sooriakumaran P, Sridhar A. Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy. Journal Of Robotic Surgery 2022, 16: 1419-1426. PMID: 35192106, DOI: 10.1007/s11701-022-01383-z.
- Zhao H, Chan V, Castellani D, Chan E, Ong W, Peng Q, Moschini M, Krajewski W, Pradere B, Ng C, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan W, Kelly J, Shariat S, Witjes J, Teoh J. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Frontiers In Surgery 2021, 8: 775527. PMID: 34888347, PMCID: PMC8649716, DOI: 10.3389/fsurg.2021.775527.
- Zhao H, Chan V, Castellani D, Chan E, Ong W, Peng Q, Moschini M, Krajewski W, Pradere B, Ng C, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan W, Kelly J, Shariat S, Witjes J, Teoh J. 1459 Intravesical Chemohyperthermia Versus Bacillus Calmette-Guerin Instillation for Intermediate- And High-Risk Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. British Journal Of Surgery 2021, 108: znab259.955. DOI: 10.1093/bjs/znab259.955.
- Tan W, Leow J, Marchese M, Sridhar A, Hellawell G, Mossanen M, Teoh J, Fowler S, Colquhoun A, Cresswell J, Catto J, Trinh Q, Kelly J, Section of Oncology O. Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit. European Urology Open Science 2021, 33: 1-10. PMID: 34723215, PMCID: PMC8546928, DOI: 10.1016/j.euros.2021.08.005.
- Tan W, Leow J, Marchese M, Sridhar A, Hellawell G, Mossanen M, Teoh J, Fowler S, Colquhoun A, Cresswell J, Catto J, Trinh Q, Kelly J. PD59-10 FACTORS ASSOCIATED WITH HIGH-QUALITY SURGERY FOLLOWING RADICAL CYSTECTOMY: ANALYSIS OF THE BRITISH ASSOCIATION OF UROLOGICAL SURGEONS (BAUS) CYSTECTOMY AUDIT. Journal Of Urology 2021, 206: e1057-e1058. DOI: 10.1097/ju.0000000000002096.10.
- Abozaid M, Tan W, Khetrapal P, Baker H, Duncan J, Sridhar A, Briggs T, Selim M, Abdallah M, Elmahdy A, Elserafy F, Kelly J. Recovery of health‐related quality of life in patients undergoing robot‐assisted radical cystectomy with intracorporeal diversion. BJU International 2021, 129: 72-79. PMID: 34092021, DOI: 10.1111/bju.15505.
- Chan V, Tan W, Asif A, Ng A, Gbolahan O, Dinneen E, To W, Kadhim H, Premchand M, Burton O, Koe J, Wang N, Leow J, Giannarini G, Vasdev N, Shariat S, Enikeev D, Ng C, Teoh J. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis. Cancers 2021, 13: 3274. PMID: 34208888, PMCID: PMC8268689, DOI: 10.3390/cancers13133274.
- Albisinni S, Moschini M, Di Trapani E, Soria F, Mari A, Aziz A, Teoh J, Laukhtina E, Mori K, D’Andrea D, Carrion D, Krajewski W, Abufaraj M, Cimadamore A, Tan W, Flippot R, Khalifa J, Gonsette K, Pradere B. Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers. World Journal Of Urology 2021, 40: 1317-1323. PMID: 34076754, DOI: 10.1007/s00345-021-03746-x.
- Tan W, Leow J, Marchese M, Sridhar A, Hellawell G, Mossanen M, Teoh J, Fowler S, Colquhoun A, Cresswell J, Catto J, Trinh Q, Kelly J. P0827 Defining factors associated with high-quality surgery following radical cystectomy: Analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit. European Urology 2021, 79: s1151. DOI: 10.1016/s0302-2838(21)01202-1.
- Zhao H, Chan V, Castellani D, Chan E, Ong W, Peng Q, Moschini M, Krajewski W, Pradere B, Ng C, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan W, Kelly J, Shariat S, Witjes J, Teoh J. P0773 Intravesical chemohyperthermia versus bacillus calmette-guerin instillation for intermediate- and high-risk non-muscle invasive bladder cancer: A systematic review and meta-analysis. European Urology 2021, 79: s1068-s1069. DOI: 10.1016/s0302-2838(21)01148-9.
- Chan V, Tan W, Leow J, Tan W, Ong W, Chiu P, Gurung P, Pirola G, Orecchia L, Liew M, Lee H, Wang Y, Chen I, Castellani D, Wroclawski M, Mayor N, Sathianathen N, Braga I, Liu Z, Moon D, Tikkinen K, Kamat A, Meng M, Ficarra V, Giannarini G, Teoh J. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic. World Journal Of Urology 2021, 39: 4295-4303. PMID: 34031748, PMCID: PMC8143063, DOI: 10.1007/s00345-021-03734-1.
- Tan W, Marchese M, Paciotti M, Nguyen D, Cone E, Mossanen M, Webster J, Barod R, Bex A, Kibel A, Chang S, Trinh Q. Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urologica E Nefrologica 2021, 73: 404-406. PMID: 33781018, DOI: 10.23736/s2724-6051.20.04197-1.
- Tan W, Kelly J. Is delay to radical cystectomy following BCG failure oncologically safe? Nature Reviews Urology 2021, 18: 323-324. PMID: 33772157, DOI: 10.1038/s41585-021-00457-1.
- Tan W, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, Pal R, Fowler W, Heer R, Elajnaf M, Douglas-Moore J, Griffiths T, Voss J, Wilby D, Al Kadhi O, Noel J, Vasdev N, McKay A, Ahmad I, Abu-Nayla I, Lamb B, Hill G, Narahari K, Kynaston H, Yousuf A, Kusuma V, Cresswell J, Cooke P, Chakravarti A, Barod R, Bex A, Kelly J, group O. Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes. European Urology Open Science 2021, 25: 39-43. PMID: 33458711, PMCID: PMC7796655, DOI: 10.1016/j.euros.2021.01.005.
- Tan W, Wong A, Mahmalji W, Raza A. Is there still a role for digital rectal examination in the prostate cancer diagnostic pathway in the COVID-19 and post COVID-19 era? The Aging Male 2021, 24: 92-94. PMID: 34319201, DOI: 10.1080/13685538.2020.1786047.
- Woldu S, Ng C, Loo R, Slezak J, Jacobsen S, Tan W, Kelly J, Lough T, Darling D, van Kessel K, de Jong J, van Criekinge W, Shariat S, Hiar A, Brown S, Boorjian S, Barocas D, Svatek R, Lotan Y. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. Journal Of Urology 2020, 205: 1387-1392. PMID: 33356483, DOI: 10.1097/ju.0000000000001550.
- Mortezavi A, Crippa A, Edeling S, Pokupic S, Dell’Oglio P, Montorsi F, D'Hondt F, Mottrie A, Decaestecker K, Wijburg C, Collins J, Kelly J, Tan W, Sridhar A, John H, Canda A, Schwentner C, Rönmark E, Wiklund P, Hosseini A. Morbidity and mortality after robot‐assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group. BJU International 2020, 127: 585-595. PMID: 33058469, PMCID: PMC8246851, DOI: 10.1111/bju.15274.
- Tan W, Marchese M, Sridhar A, Hellawell G, Mossanen M, Fowler S, Colquhoun A, Kelly J, Trinh Q. PT415 Defining factors associated with quality surgery following radical cystectomy: Analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit. European Urology Open Science 2020, 19: e2284. DOI: 10.1016/s2666-1683(20)34149-5.
- Abozaid M, Tan W, Khetrapal P, Baker H, Selim M, Abdallah M, Mahdy A, Elserafy F, Kelly J. 1104 Prospective evaluation of health related quality of life after robotic radical cystectomy with intracorporeal diversion. European Urology Open Science 2020, 19: e1641. DOI: 10.1016/s2666-1683(20)33695-8.
- Tan W, Chiancone F, Fedelini P, Boormans J, De Jong J, Wilby D, Robinson R, Poggio M, Escudero J, Goizueta F, Plata A, Vögeli T, Escandón A, Nzeh C, De La Morena J, Moreno J, Guerrero F, Torres J, Hendricksen K. 776 Intravesical chemohyperthermia (HIVEC-E) in BCG unresponsive non-muscle invasive bladder cancer patients: Oncological outcomes of a multi-centre European registry. European Urology Open Science 2020, 19: e1181-e1182. DOI: 10.1016/s2666-1683(20)33376-0.
- Paciotti M, Nguyen D, Lander A, Harrison S, Tan W, Von Landenberg N, Lughezzani G, Buffi N, Chang S, Trinh Q. 596 Rates and predictors of conversion to open surgery during laparoscopic and robotic nephrectomy. European Urology Open Science 2020, 19: e928-e929. DOI: 10.1016/s2666-1683(20)33199-2.
- Ahmed Y, Hussein A, May P, Ahmad B, Khan A, Benkowski J, Durrani A, Khan S, Kozlowski J, Saar M, Wijburg C, Richstone L, Wagner A, Yuh B, Redorta J, Dasgupta P, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Pini G, Schanne F, Mottrie A, Rha K, Hemal A, Stockle M, Kelly J, Tan W, Maatman T, Poulakis V, Kaouk J, Canda A, Balbay M, Wiklund P, Guru K. Quality of surgical care can impact survival in patients with bladder cancer after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. African Journal Of Urology 2020, 26: 22. DOI: 10.1186/s12301-020-00031-y.
- Tan W, Wang Y, Trinh Q, Preston M, Kelly J, Hrouda D, Kibel A, Krasnow R, Liu J, Chung B, Chang S, Mossanen M. Delayed blood transfusion is associated with mortality following radical cystectomy. Scandinavian Journal Of Urology 2020, 54: 290-296. PMID: 32538224, DOI: 10.1080/21681805.2020.1777195.
- Mukherjee S, Sinha R, Mandal S, Tan W. Primary Urethral Tuberculosis With Urethrocutaneous Fistula in Association With Balanitis Xerotica Obliterans. Urology 2020, 141: e20-e21. PMID: 32325139, DOI: 10.1016/j.urology.2020.04.035.
- Tan W, Kelly J. Editorial Comment. Journal Of Urology 2020, 204: 56-57. PMID: 32282283, DOI: 10.1097/ju.0000000000000786.02.
- Berg S, Tully K, Sahraoui A, Tan W, Krimphove M, Marchese M, Lipsitz S, Noldus J, Trinh Q. Inequity in selective referral to high-volume hospitals for genitourinary malignancies. Urologic Oncology Seminars And Original Investigations 2020, 38: 582-589. PMID: 32217041, DOI: 10.1016/j.urolonc.2020.02.013.
- Tan W, Teo C, Chan D, Ang K, Heinrich M, Feber A, Sarpong R, Williams N, Brew‐Graves C, Ng C, Kelly J, Khetrapal P, Sridhar A, Baker H, Ocampo F, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Heeney E, Green K, Evans S, Rogers M, Dann A, Cook J, Cornwell M, Mills R, Knight H, Maher S, Rane A, Thomas S, Reyner S, Vallejera G, Adeniran P, Masood S, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Srirangam S, Mistry R, Chadwick J, Cocks S, Hull R, Loftus A, Dawson L, Roberts H, Main C, Jain S, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Hicks J, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, Sinclair A, Storr E, Cogley L, Natale S, Lovegrove W, Smith S, Smith K, Hewitt D, Sriram R, Atkinson K, Royle L, Madine J, MacLean K, Walsh J, Guerdette A, Hill M, Payne D, Power A, Cannon J, Devereaux L, Thompson A, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Wardle H, Wilson D, Bayles A, Pelluri S, Pati J, Gherman A, Scott C, Madaan S, Taylor J, Edmunds E, Moore J, Rees A, Williams S, Caddy S, Dukes S, Goffe A, Buckhorn K, Nichols L, Acher P, Baillie K, Middleton K, Proctor C, Cresswell J, Chilvers A, Cain M, Vaux A, Watson D, Bradfield S, Gregory H, Mostafid H, Kehoe L, Drakeley S, Davies J, Williamson L, Krishnan R, Lunt N, Hill P, Burns H, Townley B, Wilkinson L, Wassall H, Sinclair A, Hunt J, Holbrook B, Stancombe L, Morrison J, Vankoutrik L, Misra S, Fossey G, Richards A, Mcdonald K, Henderson A, Fennelly R, Tribbeck M, Ames K, Borwell J, Kotze M, Beesley K, Rennie K, Porter T, Gipson A, Piper L, Bailey L, Chrisopoulou A, Slevin K, McCartin F, Warburton H, Hathaway‐Lees S, Whetton K, Delves G, Day A, Bankole T, Broadhead S, Malde S, Oblak M, Ellis D, Bishara S, Barias‐Lara T, Donkov I, Thatcher H, Morris H, Culmsee C, Menzies A, Bartlett C, Cutting C, O'Brien N, Jannapureddy R, Kelkar A, Fitzgerald J, Longhurst S, Worth C, Peracha A, Mzazi S, Poile C, Griffiths L, Cook A, Barber N, Brar N, Alty A, Zelhof B, Blades R. Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach. BJU International 2020, 125: 669-678. PMID: 31975539, PMCID: PMC7318301, DOI: 10.1111/bju.15008.
- Mukherjee S, Sinha R, Mandal S, Tan W. Spontaneous Ureterocutaneous Fistula Secondary to Obstructed Ureteric Stone. Urology 2020, 138: e5-e7. PMID: 31958535, DOI: 10.1016/j.urology.2020.01.013.
- Tan W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, Kilbridge K, Vale J, Khoubehi B, Kibel A, Sun M, Chang S, Sammon J. Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis. Urologic Oncology Seminars And Original Investigations 2019, 38: 74.e13-74.e20. PMID: 31864937, DOI: 10.1016/j.urolonc.2019.11.008.
- Cox E, Saramago P, Kelly J, Porta N, Hall E, Tan W, Sculpher M, Soares M. Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT Trial. Clinical Genitourinary Cancer 2019, 18: e418-e442. PMID: 32144049, PMCID: PMC7427321, DOI: 10.1016/j.clgc.2019.12.004.
- Jubber I, Shariat S, Conroy S, Tan W, Gordon P, Lotan Y, Messing E, Stenzl A, Rhijn B, Kelly J, Catto J, Cumberbatch M. Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European Urology 2019, 77: 583-598. PMID: 31791622, DOI: 10.1016/j.eururo.2019.10.010.
- Tan W, Tan W, Inman B. PD-L1/PD-1 Biomarker for Metastatic Urothelial Cancer that Progress Post-platinum Therapy: A Systematic Review and Meta-analysis. Bladder Cancer 2019, 5: 211-223. PMID: 31867425, PMCID: PMC6919639, DOI: 10.3233/blc-190238.
- Sridhar A, Tan W, Rawlinson A, Pavan N, Gu D, Shaw G, Nathan S, Rajan P, Kelkar A, Allen C, Sooriakumaran P, Briggs T. PE38 Determining adverse risk factors for urinary continence recovery after robotic radical prostatectomy and methods to enable early recovery. European Urology Open Science 2019, 18: e2602. DOI: 10.1016/s1569-9056(19)32724-1.
- Mortezavi A, Edeling S, Pokupic S, Dell’oglio P, Montorsi F, D'hondt F, Mottrie A, Decaestecker K, Wijburg C, Kelly J, Tan W, Sridhar A, John H, Canda E, Schwentener C, Rönmark E, Wiklund P, Hosseini A. PE61 Survival outcome after robotic assisted radical cystectomy with intracorporal urinary diversion in elderly patients. European Urology Open Science 2019, 18: e2636. DOI: 10.1016/s1569-9056(19)32747-2.
- Moschini M, Zamboni S, Soria F, Mathieu R, Xylinas E, Tan W, Kelly J, Simone G, Meraney A, Krishna S, Konety B, Mattei A, Baumeister P, Mordasini L, Montorsi F, Briganti A, Gallina A, Stabile A, Sanchez-Salas R, Cathelineau X, Rink M, Necchi A, Karakiewicz P, Rouprêt M, Koupparis A, Kassouf W, Scherr D, Ploussard G, Boorjian S, Lotan Y, Sooriakumaran P, Shariat S. Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes. Journal Of Clinical Medicine 2019, 8: 1192. PMID: 31395826, PMCID: PMC6722857, DOI: 10.3390/jcm8081192.
- Tan W, Krimphove M, Cole A, Marchese M, Berg S, Lipsitz S, Löppenberg B, Nabi J, Abdollah F, Choueiri T, Kibel A, Sooriakumaran P, Trinh Q. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer. Clinical Genitourinary Cancer 2019, 17: e1060-e1068. PMID: 31303561, DOI: 10.1016/j.clgc.2019.06.008.
- Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D`Andrea D, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Krishna S, Konety B, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Koupparis A, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M, Urologists U. Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU International 2019, 124: 656-664. PMID: 31055865, DOI: 10.1111/bju.14791.
- Thompson J, Sridhar A, Tan W, Freeman A, Haider A, Allen C, Moore C, Orczyk C, Mazzon G, Khetrapal P, Shaw G, Rajan P, Mohammed A, Briggs T, Nathan S, Kelly J, Sooriakumaran P. Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound. Journal Of Urology 2019, 201: 1134-1143. PMID: 30730409, DOI: 10.1097/ju.0000000000000135.
- Mossanen M, Krasnow R, Zlatev D, Tan W, Preston M, Trinh Q, Kibel A, Sonpavde G, Schrag D, Chung B, Chang S. Examining the relationship between complications and perioperative mortality following radical cystectomy: a population‐based analysis. BJU International 2019, 124: 40-46. PMID: 30499636, DOI: 10.1111/bju.14636.
- Tan* W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Waisbrod S, Hermanns T, Sasieni P, Kelly J. PD66-05 DEVELOPMENT AND VALIDATION OF A HEMATURIA CANCER RISK SCORE TO IDENTIFY PATIENTS AT RISK OF HARBOURING CANCER. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000557467.24162.d4.
- Tan* W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, Kilbridge K, Kibel A, Sun M, Chang S, Sammon J. PD46-02 DELAYED NEPHRECTOMY HAS COMPARABLE LONG-TERM OVERALL SURVIVAL TO IMMEDIATE NEPHRECTOMY FOR CT1A RENAL CELL CARCINOMA: A RETROSPECTIVE COHORT STUDY. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000556746.68596.8e.
- Zamboni* S, Soria F, Mathieu R, Xylinas E, D'Andrea D, Abufaraj M, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Krishna S, Konety B, Montorsi F, Briganti A, Mattei A, Baumeister P, Antonelli A, Simeone C, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Perry M, Rowe E, Koupparis A, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M. MP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555883.61031.df.
- Tan* W, Hendricksen K, Wilby D, Nzeh C, Goizueta J, Vilmar W, Bello A, Sousa A, Morena J, Pontones J, Guerrero F, Kalchev I, Frank E, Boormans J. PD13-10 ONCOLOGICAL OUTCOMES OF BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH POSTOPERATIVE CHEMOHYPERTHERMIA: A MULTICENTRE EUROPEAN RETROSPECTIVE ANALYSIS. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555390.06113.0b.
- Tan W, Kelly J, Tan W. The investigation of haematuria and bladder cancer. Trends In Urology & Men's Health 2019, 10: 25-27. DOI: 10.1002/tre.685.
- Tan W, Teo C, Chan D, Heinrich M, Feber A, Sarpong R, Allan J, Williams N, Brew‐Graves C, Ng C, Kelly J, Khetrapal P, ridhar A, Baker H, Ocampo F, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Heeney E, Green K, Evans S, Rogers M, Dann A, Cook J, Cornwell M, Mills R, Knight H, Maher S, Rane A, Thomas S, Reyner S, Vallejera G, Adeniran P, Masood S, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Srirangam S, Mistry R, Chadwick J, Cocks S, Hull R, Loftus A, Dawson L, Roberts H, Main C, Jain S, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Hicks J, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, inclair A, Storr E, Cogley L, Natale S, Lovegrove W, Smith S, Smith K, Hewitt D, Sriram R, Atkinson K, Royle L, Madine J, MacLean K, Walsh J, Guerdette M, Hill M, Payne D, Power A, Cannon J, Devereaux L, Thompson A, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Wardle H, Wilson D, Bayles A, Pelluri S, Pati J, Gherman A, Scott C, Madaan S, Taylor A, Edmunds E, Moore J, Rees A, Williams S, Caddy S, Dukes S, Goffe A, Buckhorn K, Nichols L, Acher P, Baillie K, Middleton K, Proctor C, Cresswell J, Chilvers A, Cain M, Vaux A, Watson D, Bradfield S, Gregory H, Mostafid H, Kehoe L, Drakeley S, Davies A, Williamson L, Krishnan R, Lunt N, Hill P, Burns H, Townley B, Wilkinson L, Wassall H, Hunt J, Holbrook B, Stancombe L, Morrison J, Vankoutrik L, Misra S, Fossey G, Richards A, Mcdonald K, Henderson A, Fennelly R, Tribbeck M, Ames K, Borwell J, Kotze M, Beesley K, Rennie K, Porter T, Gipson A, Piper L, Bailey L, Chrisopoulou A, Slevin K, McCartin F, Warburton H, Hathaway‐Lees S, Whetton K, Delves G, Day A, Bankole T, Broadhead S, Malde S, Oblak M, Ellis D, Bishara S, Barias‐Lara T, Donkov I, Thatcher H, Morris M, Culmsee C, Menzies H, Bartlett C, Cutting C, O'Brien N, Jannapureddy R, Kelkar A, Fitzgerald J, Longhurst S, Worth C, Peracha M, Mzazi S, Poile C, Griffiths L, Cook A, Barber N, Brar N, lty A, Zelhof B, Blades R. Mixed‐methods approach to exploring patients’ perspectives on the acceptability of a urinary biomarker test in replacing cystoscopy for bladder cancer surveillance. BJU International 2019, 124: 408-417. PMID: 30694612, PMCID: PMC6767410, DOI: 10.1111/bju.14690.
- Tan W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Hermanns T, Waisbrod S, Sasieni P, Kelly J. 182 Development and external validation of the haematuria cancer risk score to identify patient at risk of harbouring cancer. European Urology Open Science 2019, 18: e247-e249. DOI: 10.1016/s1569-9056(19)30179-4.
- Zamboni S, Soria F, Mathieu R, Xylinas E, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Konety B, Antonelli A, Simeone C, Baumeister P, Mattei A, Montorsi F, Briganti A, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M, Urologists U. 843 Comparative effectiveness of robotic assisted and open radical cystectomy in contemporary cohorts of bladder cancer patients: An international multicenter collaboration. European Urology Open Science 2019, 18: e1139-e1140. DOI: 10.1016/s1569-9056(19)30821-8.
- Tan W, Krimphove M, Cole A, Berg S, Marchese M, Lipsitz S, Loppenberg B, Nabi J, Abdollah F, Choueiri T, Kibel A, Sooriakumaran P, Trinh Q. 222 Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer. European Urology Open Science 2019, 18: e294-e295. DOI: 10.1016/s1569-9056(19)30214-3.
- Mossanen M, Wang Y, Szymaniak J, Tan W, Huynh M, Preston M, Trinh Q, Sonpavde G, Schrag D, Kibel A, Chang S. 705 Evaluating the cost of surveillance for non-muscle invasive bladder cancer: An economic analysis based on risk categories. European Urology Open Science 2019, 18: e942. DOI: 10.1016/s1569-9056(19)30685-2.
- Tan W, Berg S, Cole A, Krimphove M, Marchese M, Lipsitz S, Nabi J, Sammon J, Choueiri T, Kibel A, Sun M, Chang S, Trinh Q. 1056 Comparing long-term outcomes following radical and partial nephrectomy for cT1 renal cell carcinoma in young and healthy individuals. European Urology Open Science 2019, 18: e1423-e1424. DOI: 10.1016/s1569-9056(19)31027-9.
- Tan W, Trinh Q, Hayn M, Marchese M, Lipsitz S, Nabi J, Kilbridge K, Kibel A, Sun M, Chang S, Sammon J. 913 Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A retrospective cohort study. European Urology Open Science 2019, 18: e1235-e1236. DOI: 10.1016/s1569-9056(19)30887-5.
- Berg S, Pucheril D, Sahraoui A, Tan W, Krimphove M, Marchese M, Lipsitz S, Noldus J, Kibel A, Trinh Q. PT392 Barriers to selective referral of genitourinary cancers to high- vs. low-volume hospitals. European Urology Open Science 2019, 18: e2202-e2203. DOI: 10.1016/s1569-9056(19)31592-1.
- Tan W, Teo C, Chan D, Heinrich M, Feber A, Sarpong R, Allan J, Williams N, Brew-Graves C, Ng C, Kelly J. 227 Mix methods approach to determine patients’ perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy for bladder cancer surveillance. European Urology Open Science 2019, 18: e303. DOI: 10.1016/s1569-9056(19)30219-2.
- Tan W, Berg S, Cole A, Krimphove M, Marchese M, Lipsitz S, Nabi J, Sammon J, Choueiri T, Kibel A, Sun M, Chang S, Trinh Q. Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals. JNCI Cancer Spectrum 2019, 3: pkz003. PMID: 31360891, PMCID: PMC6649692, DOI: 10.1093/jncics/pkz003.
- Tan W, Ahmad A, Feber A, Mostafid H, Cresswell J, Fankhauser C, Waisbrod S, Hermanns T, Sasieni P, Kelly J, Khetrapal P, Baker H, Sridhar A, Lamb B, Ocampo F, McBain H, Baillie K, Middleton K, Watson D, Knight H, Maher S, Rane A, Pathmanathan B, Harmathova A, Hellawell G, Pelluri S, Pati J, Cossons A, Scott C, Madaan S, Bradfield S, Wakeford N, Dann A, Cook J, Cornwell M, Mills R, Thomas S, Reyner S, Vallejera G, Adeniran P, Masood S, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Heeney E, Green K, Evans S, Rogers M, Gupwell K, Whiteley S, Brown A, McGrath J, Lunt N, Hill P, Sinclair A, Paredes‐Guerra A, Holbrook B, Ong E, Wardle H, Wilson D, Bayles A, Fennelly R, Tribbeck M, Ames K, Davies M, Taylor J, Edmunds E, Moore J, Mckinley S, Nolan T, Speed A, Tunnicliff A, Fossey G, Williams A, George M, Hutchins I, Einosas R, Richards A, Henderson A, Appleby B, Kehoe L, Gladwell L, Drakeley S, Davies J, Krishnan R, Roberts H, Main C, Jain S, Dumville J, Wilkinson N, Taylor J, Thomas F, Goulden K, Vinod C, Green E, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Srirangam S, Rees A, Williams S, Dukes S, Goffe A, Dawson L, Mistry R, Chadwick J, Cocks S, Hull R, Loftus A, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Hicks J, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, Sinclair A, Storr E, Cogley L, Natale S, Lovegrove W, Slack K, Nash D, Smith K, Walsh J, Guerdette A, Hill M, Payne D, Taylor B, Sinclair E, Perry M, Debbarma M, Hewitt D, Sriram R, Power A, Cannon J, Devereaux L, Thompson A, Atkinson K, Royle L, Madine J, MacLean K, Sarpong R, Brew‐Graves C, Williams N. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer. Journal Of Internal Medicine 2019, 285: 436-445. PMID: 30521125, PMCID: PMC6446724, DOI: 10.1111/joim.12868.
- Tan W, Kelly J. Is experience with extracorporeal urinary diversion following robotic assisted radical cystectomy necessary before transitioning to intracorporeal urinary diversion? Translational Andrology And Urology 2018, 0: s735-s737. PMID: 30687611, PMCID: PMC6323277, DOI: 10.21037/tau.2018.08.22.
- Mossanen M, Wang Y, Szymaniak J, Tan W, Huynh M, Preston M, Trinh Q, Sonpavde G, Kibel A, Chang S. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World Journal Of Urology 2018, 37: 2059-2065. PMID: 30446799, DOI: 10.1007/s00345-018-2550-x.
- Moschini M, Soria F, Mathieu R, Xylinas E, D'Andrea D, Tan W, Kelly J, Simone G, Tuderti G, Meraney A, Krishna S, Konety B, Zamboni S, Baumeister P, Mattei A, Briganti A, Montorsi F, Galucci M, Rink M, Karakiewicz P, Rouprêt M, Aziz A, Perry M, Rowe E, Koupparis A, Kassouf W, Scherr D, Ploussard G, Boorjian S, Sooriakumaran P, Shariat S, Urologists U. Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy. Urologic Oncology Seminars And Original Investigations 2018, 37: 179.e1-179.e7. PMID: 30446442, DOI: 10.1016/j.urolonc.2018.10.012.
- Kelly J, Tan W, Porta N, Mostafid H, Huddart R, Protheroe A, Bogle R, Blazeby J, Palmer A, Cresswell J, Johnson M, Brough R, Madaan S, Andrews S, Cruickshank C, Burnett S, Maynard L, Hall E, Investigators O. BOXIT—A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004). European Urology 2018, 75: 593-601. PMID: 30279015, DOI: 10.1016/j.eururo.2018.09.020.
- Tan W, Panchal A, Buckley L, Devall A, Loubière L, Pope A, Feneley M, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths T, Page T, Hodgson D, Datta S, Billingham L, Kelly J. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial. European Urology 2018, 75: 63-71. PMID: 30274699, DOI: 10.1016/j.eururo.2018.09.005.
- Wong Y, Joshi K, Khetrapal P, Ismail M, Reading J, Sunderland M, Georgiou A, Furness A, Aissa A, Ghorani E, Oakes T, Uddin I, Tan W, Feber A, McGovern U, Swanton C, Freeman A, Marafioti T, Briggs T, Kelly J, Powles T, Peggs K, Chain B, Linch M, Quezada S. Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment. Journal Of Experimental Medicine 2018, 215: 2748-2759. PMID: 30257862, PMCID: PMC6219732, DOI: 10.1084/jem.20181003.
- Tan W, Kelly J. Intravesical device-assisted therapies for non-muscle-invasive bladder cancer. Nature Reviews Urology 2018, 15: 667-685. PMID: 30254383, DOI: 10.1038/s41585-018-0092-z.
- Thompson J, Sridhar A, Tan W, Khetrapal P, Mazzon G, Shaw G, Rajan P, Alkadhi O, Di G, Briggs T, Nathan S, Sooriakumaran P, Kelly J. PE35 Pathologic findings and MRI concordance at salvage RARP for local recurrence following high-intensity focused ultrasound (HIFU) therapy: High rate of adverse prognostic features and poor sensitivity of MRI. European Urology Open Science 2018, 17: e2296. DOI: 10.1016/s1569-9056(18)32698-8.
- Tan W, Sarpong R, Khetrapal P, Rodney S, Mostafid H, Cresswell J, Watson D, Rane A, Hicks J, Hellawell G, Davies M, Srirangam S, Dawson L, Payne D, Williams N, Brew‐Graves C, Feber A, Kelly J, Sridhar A, Lamb B, Ocampo F, McBain H, Baillie K, Middleton K, Knight H, Maher S, Pathmanathan B, Harmathova A, Pelluri S, Pati J, Cossons A, Scott C, Madaan S, Bradfield S, Wakeford N, Dann, Cook J, Cornwell M, Mills R, Thomas, Reyner S, Vallejera G, Adeniran P, Masood S, Whotton N, Dent K, Pearson S, Hatton J, Newton M, Hheeney E, Green K, Evans S, Rogers M, Gupwell K, ley S, Brown A, McGrath J, Lunt N, Hill P, inclair A, Paredes‐Guerra A, Holbrook B, Ong E, Wardle H, Wilson D, Bayles A, Fennelly R, Tribbeck M, Ames K, Taylor J, Edmunds E, Moore J, Mckinley S, Nolan T, peed A, Tunnicliff A, Fossey G, Williams A, George M, Hutchins I, Einosas R, Richards A, Henderson A, Appleby B, Kehoe L, Gladwell L, Drakeley S, Davies J, Krishnan R, Roberts H, Main C, Jain S, Dumville J, Wilkinson N, Taylor J, Thomas F, Goulden K, Vinod C, Green E, Waymont C, Rogers J, Grant A, Carter V, Heap H, Lomas C, Cooke P, Scarratt L, Hodgkiss T, Johnstone D, Johnson J, Allsop J, Rothwell J, Connolly K, Cherian J, Ridgway S, Coulding M, Savill H, Mccormick J, Clark M, Collins G, Jewers K, Keith S, Bowen G, Hargreaves J, Riley K, Rees A, Williams S, Dukes S, Goffe A, Mistry R, Chadwick J, Cocks S, Hull R, oftus A, Baird Y, Moore S, Greenslade S, Margalef J, Chadbourn I, Harris M, Clitheroe P, Connolly S, Hodgkinson S, Haydock H, Storr E, Cogley L, Natale S, Lovegrove W, Slack K, Nash D, Smith K, Walsh J, Guerdette A, Hill M, Taylor B, Sinclair E, Perry M, Debbarma M, Hewitt D, Sriram R, Power A, Cannon J, Devereaux L, Thompson A, Atkinson K, Royle L, Madine J, MacLean K. Does urinary cytology have a role in haematuria investigations? BJU International 2018, 123: 74-81. PMID: 30003675, PMCID: PMC6334509, DOI: 10.1111/bju.14459.
- Tan W, Tan W, Tan M, Khetrapal P, Dong L, deWinter P, Feber A, Kelly J. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treatment Reviews 2018, 69: 39-52. PMID: 29902678, DOI: 10.1016/j.ctrv.2018.05.012.
- Tan W, Sarpong R, Khetrapal P, Rodney S, Mostafid H, Cresswell J, Hicks J, Rane A, Henderson A, Watson D, Cherian J, Williams N, Brew-Graves C, Feber A, Kelly J, Collaborators D. Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria? Journal Of Urology 2018, 200: 973-980. PMID: 29702097, PMCID: PMC6179963, DOI: 10.1016/j.juro.2018.04.065.
- Khetrapal P, Lee M, Tan W, Dong L, de Winter P, Feber A, Kelly J. The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review. Cancer Treatment Reviews 2018, 66: 56-63. PMID: 29684744, DOI: 10.1016/j.ctrv.2018.03.007.
- Tan W, Feber A, Sarpong R, Khetrapal P, Rodney S, Jalil R, Mostafid H, Cresswell J, Hicks J, Rane A, Henderson A, Watson D, Cherian J, Williams N, Brew-Graves C, Kelly J, collaborators O. Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. European Urology 2018, 74: 10-14. PMID: 29653885, DOI: 10.1016/j.eururo.2018.03.008.
- Tan W, Feber A, Dong L, Sarpong R, Rodney S, Khetrapal P, de Winter P, Jalil R, Williams N, Brew-Graves C, Kelly J, group D. MP63-15 CAN RENAL TRACT ULTRASOUND REPLACE CT UROGRAPHY FOR THE EVALUATION OF MICROSCOPIC HEMATURIA? RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY. Journal Of Urology 2018, 199: e846-e847. DOI: 10.1016/j.juro.2018.02.2038.
- Hussein A, May P, Jing Z, Ahmed Y, Wijburg C, Richstone L, Wagner A, Redorta J, Badani K, Khan H, Saar M, Stockle M, Dasgupta P, Kawa O, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Pini G, Schanne F, Poulakis V, Weizer A, Kelly J, Tan W, Maatman T, Canda A, Mottrie A, Kaouk J, Yuh B, Rha K, Hemal A, Peak T, Wiklund P, Guru K. MP49-01 OUTCOMES OF INTRACORPOREAL URINARY DIVERSION AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM. Journal Of Urology 2018, 199: e665. DOI: 10.1016/j.juro.2018.02.1592.
- Tan W, Feber A, Dong L, Sarpong R, Rodney S, Khetrapal P, de Winter P, Jalil R, Williams N, Brew-Graves C, Kelly J, group D. MP06-06 DOES URINARY CYTOLOGY HAVE A ROLE IN HEMATURIA INVESTIGATIONS? RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY (DETECT I). Journal Of Urology 2018, 199: e54. DOI: 10.1016/j.juro.2018.02.198.
- Tan W, Feber A, Dong L, Sarpong R, Rodney S, Khetrapal P, de Winter P, Jalil R, Williams N, Brew-Graves C, Kelly J, group D. MP06-08 WHO SHOULD BE EVALUATED FOR HEMATURIA? A COMPARISON OF INTERNATIONAL GUIDELINES. Journal Of Urology 2018, 199: e54-e55. DOI: 10.1016/j.juro.2018.02.200.
- Hussein A, May P, Jing Z, Ahmed Y, Wijburg C, Canda A, Balbay M, Dasgupta P, Khan M, Kawa O, Hosseini A, Menon M, Peabody J, Kelly J, Mottrie A, Gaboardi F, Pini G, Kaouk J, Hemal A, Redorta J, Stockle M, Saar M, Yuh B, Badani K, Tan W, Poulakis V, Weizer A, Wiklund P, Guru K. MP49-02 COMPARING EXTRA-CORPOREAL AND INTRA-CORPOREAL NEOBLADDERS AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM. Journal Of Urology 2018, 199: e665-e666. DOI: 10.1016/j.juro.2018.02.1593.
- Tan W, Tan W. Urinary biomarker for the detection of recurrence following non- muscle invasive bladder cancer: are we there yet? Translational Andrology And Urology 2018, 7: s109-s110. PMID: 29644175, PMCID: PMC5881187, DOI: 10.21037/tau.2017.12.18.
- Tan W, Feber A, Sarpong R, Khetrapal P, Rodney S, Jalil R, Dong L, Rezaee S, Williams N, Brew-Graves C, Kelly J. 910 Can ultrasound renal tract replace CT intravenous urogram in patients investigated for non-visible haematuria? Results of the DETECT I study. European Urology Open Science 2018, 17: e1294. DOI: 10.1016/s1569-9056(18)31741-x.
- Khetrapal P, Dong L, Wong Y, Tan W, Rodney S, Lamb B, Briggs T, Thompson J, Sridhar A, Kelly J, Feber A. 1079 Using plasma cell-free DNA mutations to monitor patients for micro-metastatic bladder cancer after radical cystectomy. European Urology Open Science 2018, 17: e1527. DOI: 10.1016/s1569-9056(18)31902-x.
- Tan W, Feber A, Sarpong R, Jalil R, Khetrapal P, Rodney P, Dong L, Rezaee S, Wiliams N, Brew-Graves C, Kelly J. 1012 What is the role of urinary cytology as part of haematuria investigations? Results of a prospective observational study (DETECT I). European Urology Open Science 2018, 17: e1426. DOI: 10.1016/s1569-9056(18)31837-2.
- Hussein A, May P, Jing Z, Ahmed Y, Wijburg C, Canda A, Dasgupta P, Khan M, Menon M, Peabody J, Hosseini A, Kelly J, Mottrie A, Kaouk J, Hemal A, Wiklund P, Guru K, Collaborators, Wagner A, Saar M, Stockle M, Redorta J, Richstone L, Badani K, Scherr D, Khan H, Gaboardi F, Rha K, Kawa O, Tan W, Schanne F, Polakis V, Weizer A, Maatman T, Pini G, Peak T, Kibel A, Yuh B. Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Journal Of Urology 2017, 199: 1302-1311. PMID: 29275112, DOI: 10.1016/j.juro.2017.12.045.
- Tan W, Tan M, Lamb B, Sridhar A, Mohammed A, Baker H, Nathan S, Briggs T, Tan M, Kelly J. Intracorporeal robot‐assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains. BJU International 2017, 121: 632-639. PMID: 29124853, DOI: 10.1111/bju.14073.
- Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than OthersKhetrapal P, Tan W, Kelly J. Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than Others. European Urology 2017, 73: 383-384. PMID: 29174579, DOI: 10.1016/j.eururo.2017.11.004.
- Tan W, Feber A, Dong L, Sarpong R, Rezaee S, Rodney S, Khetrapal P, de Winter P, Ocampo F, Jalil R, Williams N, Brew-Graves C, Kelly J. DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells. BMC Cancer 2017, 17: 767. PMID: 29141603, PMCID: PMC5688623, DOI: 10.1186/s12885-017-3758-7.
- Tan W, Sridhar A, Kelly J. Male Robot-Assisted Radical Cystectomy. 2017, 195-205. DOI: 10.1007/978-3-319-65864-3_16.
- Hussein A, May P, Ahmed Y, Saar M, Wijburg C, Richstone L, Wagner A, Wilson T, Yuh B, Redorta J, Dasgupta P, Kawa O, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Pini G, Schanne F, Mottrie A, Rha K, Hemal A, Stockle M, Kelly J, Tan W, Maatman T, Poulakis V, Kaouk J, Canda A, Balbay M, Wiklund P, Guru K. Development of a patient and institutional‐based model for estimation of operative times for robot‐assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU International 2017, 120: 695-701. PMID: 28620985, DOI: 10.1111/bju.13934.
- Dong L, Khetrapal P, Rodney S, Tan W, Rezaee S, Winter P, Kelly J, Feber A. Abstract 5702: A targeted re-sequencing assay for molecular profiling of somatic mutations from plasma cell-free dna (cfdna) for bladder cancers. Cancer Research 2017, 77: 5702-5702. DOI: 10.1158/1538-7445.am2017-5702.
- Khetrapal P, Tan W, Lamb B, Tan M, Baker H, Thompson J, Sridhar A, Kelly J, Briggs T. The Role of Robotics in the Invasive Management of Bladder Cancer. Current Urology Reports 2017, 18: 57. PMID: 28634646, DOI: 10.1007/s11934-017-0706-7.
- Rodney S, Tanic M, Barrett J, Amy W, de Winter P, Tan W, Khetrapal P, Dong L, Rezaee S, Freeman A, Nigam R, Malone P, Muneer A, Beck S, Feber A, Kelly J. Multiregion sequencing of penile cancer to reveal distinct patterns of heterogeneous actionable mutations. Journal Of Clinical Oncology 2017, 35: 4518-4518. DOI: 10.1200/jco.2017.35.15_suppl.4518.
- Tan W, Buckley L, Devall A, Loubiére L, Pope A, Feneley M, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths L, Page T, Hodgson D, Datta S, Billingham L, Kelly J. PD19-08 RADIOFREQUENCY-INDUCED THERMO-CHEMOTHERAPY EFFECT (RITE) PLUS MITOMYCIN VERSUS A SECOND COURSE OF BACILLUS CALMETTE-GUÉRIN (BCG) OR INSTITUTIONAL STANDARD IN PATIENTS WITH RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER FOLLOWING INDUCTION OR MAINTENANCE BCG THERAPY (HYMN): A OPEN-LABEL, MULTICENTRE, PHASE III RANDOMISED CONTROLLED TRIAL. Journal Of Urology 2017, 197: e367-e368. DOI: 10.1016/j.juro.2017.02.881.
- Tan W, Palou J, Kelly J, Group H. MP15-18 SAFETY AND TOLERABILITY ANALYSIS OF HYPERTHERMIC INTRAVESICAL MITOMYCIN TO MITOMYCIN ALONE IN HIVEC I AND HIVEC II: AN ANALYSIS OF 307 PATIENTS. Journal Of Urology 2017, 197: e177. DOI: 10.1016/j.juro.2017.02.503.
- Zahran M, Abozaid M, Taha D, Lamb B, Sridhar A, Tan W, Almekaty K, Hefnawy A, Ali-El-Dein. B, Kelly J. MP10-17 HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION. OPEN VERSUS ROBOTIC ASSISTED TECHNIQUES. Journal Of Urology 2017, 197: e114-e115. DOI: 10.1016/j.juro.2017.02.345.
- May P, Dexter F, Hussein A, Ahmed Y, Hosseini A, Wiklund P, Peabody J, Ho-Rha K, Richstone L, Khan S, Wijburg C, Saar M, Canda A, Kaouk J, Wagner A, Yuh B, Redorta J, Balbay M, Maatman T, Smits G, Menon M, Stoeckle M, Kawa O, Hemal A, Pini G, Gaboardi F, Mottrie A, Kelly J, Tan W, Schanne F, Weizer A, Peak T, Guru K. MP92-05 CALCULATING SURGICAL TIME FOR ROBOT-ASSISTED RADICAL CYSTECTOMY BASED ON PATIENT RELATED METRICS & INSTITUTIONAL EXPERIENCE: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM. Journal Of Urology 2017, 197: e1227-e1228. DOI: 10.1016/j.juro.2017.02.2866.
- Khetrapal P, Dong L, Wong Y, Tan W, Rodney S, Lamb B, Sridhar A, Briggs T, Kelly J, Feber A. MP44-13 MOLECULAR TRACKING OF BLADDER CANCERUSING MUTATIONS DETECTED IN PLASMA CELL-FREE DNA THROUGH RADICAL CYSTECTOMY AND CHEMOTHERAPY. Journal Of Urology 2017, 197: e568. DOI: 10.1016/j.juro.2017.02.1344.
- Tan W, Buckley L, Devall A, Loubière L, Pope A, Feneley M, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths L, Page T, Hodgson D, Datta S, Bilingham L, Kelly J. 665 Radiofrequency-induced thermo-chemotherapy effect plus mitomycin versus a second course of bacillus Calmette-Guérin (BCG) or institutional standard in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance BCG therapy (HYMN): A phase III, open-label, randomised controlled trial. European Urology Open Science 2017, 16: e1156-e1157. DOI: 10.1016/s1569-9056(17)30720-0.
- Tan W, Palou J, Kelly J. 662 Safety and tolerability analysis of hyperthermic intravesical mitomycin to mitomycin alone in HIVEC I and HIVEC II: An interim analysis of 307 patients. European Urology Open Science 2017, 16: e1150-e1151. DOI: 10.1016/s1569-9056(17)30717-0.
- Tan W, Lamb B, Tan M, Sridhar A, Mohammed A, Baker H, Briggs T, Tan M, Kelly J. 588 Enhanced recovery enhances reduction of length of stay in patients treated with robotic assisted radical cystectomy with intracorporeal urinary diversion. European Urology Open Science 2017, 16: e1022. DOI: 10.1016/s1569-9056(17)30645-0.
- Tan W, Lamb B, Sridhar A, Briggs T, Kelly J. A Comprehensive Guide to Perioperative Management and Operative Technique for Robotic Cystectomy with Intracorporeal Urinary Diversion. Urologia Journal 2017, 84: 71-78. PMID: 28256704, DOI: 10.5301/uj.5000224.
- Feber A, Dhami P, Dong L, de Winter P, Tan W, Martínez-Fernández M, Paul D, Hynes-Allen A, Rezaee S, Gurung P, Rodney S, Mehmood A, Villacampa F, de la Rosa F, Jameson C, Cheng K, Zeegers M, Bryan R, James N, Paramio J, Freeman A, Beck S, Kelly J. UroMark—a urinary biomarker assay for the detection of bladder cancer. Clinical Epigenetics 2017, 9: 8. PMID: 28163793, PMCID: PMC5282868, DOI: 10.1186/s13148-016-0303-5.
- Tan W, Lamb B, Khetrapal P, Tan M, Tan M, Sridhar A, Cervi E, Rodney S, Busuttil G, Nathan S, Hines J, Shaw G, Mohammed A, Baker H, Briggs T, Klein A, Richards T, Kelly J. Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy. Journal Of Endourology 2017, 31: 141-148. PMID: 27901350, DOI: 10.1089/end.2016.0730.
- Hussein A, Saar M, May P, Wijburg C, Richstone L, Wagner A, Wilson T, Yuh B, Redorta J, Dasgupta P, Khan M, Menon M, Peabody J, Hosseini A, Gaboardi F, Mottrie A, Rha K, Hemal A, Stockle M, Kelly J, Maatman T, Canda A, Wiklund P, Guru K, Collaborators, Balbay M, Poulakis V, Woods M, Tan W, Kawa O, Pini G, Badani K, Ahmed Y. Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Journal Of Urology 2016, 197: 1427-1436. PMID: 27993668, DOI: 10.1016/j.juro.2016.12.048.
- Tan W, Khetrapal P, Tan W, Rodney S, Chau M, Kelly J. Robotic Assisted Radical Cystectomy with Extracorporeal Urinary Diversion Does Not Show a Benefit over Open Radical Cystectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. PLOS ONE 2016, 11: e0166221. PMID: 27820855, PMCID: PMC5098822, DOI: 10.1371/journal.pone.0166221.
- Feber A, Worth D, Chakravarthy A, de Winter P, Shah K, Arya M, Saqib M, Nigam R, Malone P, Tan W, Rodney S, Freeman A, Jameson C, Wilson G, Powles T, Beck S, Fenton T, Sharp T, Muneer A, Kelly J. CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma. Cancer Research 2016, 76: 4720-4727. PMID: 27325650, PMCID: PMC5302160, DOI: 10.1158/0008-5472.can-15-3134.
- Khetrapal P, Tan W, Lamb B, Nathan S, Briggs T, Shankar A, Ramachandran N, Freeman A, Mitra A, Kelly J. Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options. Clinical Genitourinary Cancer 2016, 15: 440-444. PMID: 28209455, DOI: 10.1016/j.clgc.2016.06.012.
- Tan W, Lamb B, Tan M, Ahmad I, Sridhar A, Nathan S, Hines J, Shaw G, Briggs T, Kelly J. In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion. European Urology Focus 2016, 3: 273-279. PMID: 28753745, DOI: 10.1016/j.euf.2016.06.002.
- Lamb B, Tan W, Eneje P, Bruce D, Jones A, Ahmad I, Sridhar A, Baker H, Briggs T, Hines J, Nathan S, Martin D, Stephens R, Kelly J. Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: A prospective cohort study. Urologic Oncology Seminars And Original Investigations 2016, 34: 417.e17-417.e23. PMID: 27197920, DOI: 10.1016/j.urolonc.2016.04.006.
- Tan W, Rodney S, Lamb B, Feneley M, Kelly J. Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treatment Reviews 2016, 47: 22-31. PMID: 27231966, DOI: 10.1016/j.ctrv.2016.05.002.
- Tan W, Tan M, Tan W, Gan S, Pathmanathan R, Tan H, Tan W. Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis: Case Report and Systematic Review of Literature. Clinical Genitourinary Cancer 2016, 14: e435-e439. PMID: 27067374, DOI: 10.1016/j.clgc.2016.03.007.
- Tan W, Sridhar A, Ellis G, Lamb B, Goldstraw M, Nathan S, Hines J, Cathcart P, Briggs T, Kelly J. Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes. Urologic Oncology Seminars And Original Investigations 2016, 34: 257.e1-257.e9. PMID: 26968561, DOI: 10.1016/j.urolonc.2016.02.010.
- Feber A, De Winter P, Dhami P, Martinez-Fernande M, Paul D, Hynes-Allen A, Tan W, Gurung P, Rodney S, Mehmood A, Jameson C, Paramio J, Bryan R, James N, Freeman A, Beck S, Kelly J. 293 UroMark - a highly multiplex biomarker for the detection of bladder cancer. European Urology Open Science 2016, 15: e293-e293a. DOI: 10.1016/s1569-9056(16)60295-6.
- Tan W, Lamb B, Kelly J. Evolution of the neobladder: A critical review of open and intracorporeal neobladder reconstruction techniques. Scandinavian Journal Of Urology 2016, 50: 95-103. PMID: 26882458, DOI: 10.3109/21681805.2016.1141318.
- Tan W, Lamb B, Kelly J. Complications of Radical Cystectomy and Orthotopic Reconstruction. Advances In Urology 2015, 2015: 323157. PMID: 26697063, PMCID: PMC4677163, DOI: 10.1155/2015/323157.
- Tan W, Sridhar A, Goldstraw M, Zacharakis E, Nathan S, Hines J, Cathcart P, Briggs T, Kelly J. Robot‐assisted intracorporeal pyramid neobladder. BJU International 2015, 116: 771-779. PMID: 26033321, DOI: 10.1111/bju.13189.
- Lamb B, Tan W, Rehman A, Nessa A, Cohen D, O'Neil J, Green J, Hines J. Is Prebiopsy MRI Good Enough to Avoid Prostate Biopsy? A Cohort Study Over a 1-Year Period. Clinical Genitourinary Cancer 2015, 13: 512-517. PMID: 26231912, DOI: 10.1016/j.clgc.2015.06.007.
- Feber A, Arya M, De Winter P, Muhammad S, Nigam R, Malone P, Tan W, Rodney S, Lechner M, Freeman A, Jameson C, Muneer A, Beck S, Kelly J. 702 Epigenomics of penile squamous cell carcinoma. European Urology Open Science 2015, 14: e702-e702a. DOI: 10.1016/s1569-9056(15)60694-7.
- Feber A, Arya M, de Winter P, Saqib M, Nigam R, Malone P, Tan W, Rodney S, Lechner M, Freeman A, Jameson C, Muneer A, Beck S, Kelly J. Epigenetics Markers of Metastasis and HPV-Induced Tumorigenesis in Penile Cancer. Clinical Cancer Research 2015, 21: 1196-1206. PMID: 25538261, PMCID: PMC4351916, DOI: 10.1158/1078-0432.ccr-14-1656.
- Tan W, Lamb B, Payne H, Hughes S, Green J, Lane T, Adshead J, Boustead G, Vasdev N. Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice. Clinical Genitourinary Cancer 2014, 13: e153-e158. PMID: 25510376, DOI: 10.1016/j.clgc.2014.11.006.
- Gurung P, Veerakumarasivam A, Williamson M, Counsell N, Douglas J, Tan W, Feber A, Crabb S, Short S, Freeman A, Powles T, Hoskin P, West C, Kelly J. Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle‐invasive bladder cancer. International Journal Of Cancer 2014, 136: 709-720. PMID: 24917520, DOI: 10.1002/ijc.29022.
- Tan W, De Winter P, Gurung P, Ip L, King K, Gewinner C, Freeman A, Bryan R, James N, Beck S, Kelly J, Feber A. 512 INPP4B knockdown confers cisplatin sensitivity in bladder cancer. European Urology Open Science 2014, 13: e512. DOI: 10.1016/s1569-9056(14)60504-2.
- Tan W, Low W, Ng C, Tan W, Tong S, Ho C, Khoo E, Lee G, Lee B, Lee V, Tan H. Efficacy and safety of long‐acting intramuscular testosterone undecanoate in aging men: a randomised controlled study. BJU International 2013, 111: 1130-1140. PMID: 23651425, DOI: 10.1111/bju.12037.
- Gurung P, Counsell N, Douglas J, Tan W, Feber A, Short S, Crabb S, West C, Hoskin P, Beltran L, Freeman A, Powles T, Kelly J. 58 DNA damage response (DDR) genes are predictive of response to radiotherapy for muscle invasive bladder cancer. European Urology Open Science 2013, 12: e58-e59. DOI: 10.1016/s1569-9056(13)60551-5.
- Feber A, Tan W, De Winter P, Freeman A, King K, Gurung P, Jameson C, Bryan R, James N, Beck S, Kelly J. 51 Epigenetic alterations associated with neo-adjuvant chemotherapy resistance in bladder cancer. European Urology Open Science 2013, 12: e51. DOI: 10.1016/s1569-9056(13)60544-8.
- Tan W, Ng C, Khoo E, Low W, Tan H. The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study). The Aging Male 2011, 14: 231-236. PMID: 22115177, DOI: 10.3109/13685538.2011.597463.
- Tan W. Biochemical Recurrence after Radical Radiotherapy for Localised Prostate Cancer — the Cardiff Experience. Clinical Oncology 2011, 23: s55. DOI: 10.1016/j.clon.2011.01.489.
- Tan W, Low W, Ng C, Khoo E, Ho E, Tan H. Overactive bladder (OAB) and its association with prostatic parameters. Journal Of Men's Health 2011, 8: s71-s74. DOI: 10.1016/s1875-6867(11)60026-2.
- Tan H, Khoo E, Ng C, Low W, Yap P, Tan W. 340 THE AGING MALES' SYMPTOMS' SCALE (AMS) - A GENERAL SCREENING INSTRUMENT FOR AGING MALES' HEALTH PROBLEM? European Urology Open Science 2007, 6: 107. DOI: 10.1016/s1569-9056(07)60339-x.
Departments and Programs